FDA901-1 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide one); ihc Anti-Actin confirmed US Biomax 858 |
FDA901-1 |
FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide one); ihc Anti-Actin confirmed |
US Biomax |
|
858€ |
|
Pub |
FDA901-2 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide two); ihc Anti-Actin confirmed US Biomax 858 |
FDA901-2 |
FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide two); ihc Anti-Actin confirmed |
US Biomax |
|
858€ |
|
Pub |
FDA901 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides.; ih US Biomax 1438 |
FDA901 |
FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides.; ih |
US Biomax |
|
1438€ |
|
Pub |
FDA902a FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides, rep US Biomax 1206 |
FDA902a |
FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides, rep |
US Biomax |
|
1206€ |
|
Pub |
FDA902 FDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organ US Biomax 199 |
FDA902 |
FDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organ |
US Biomax |
|
199€ |
|
Pub |
FDA902b FDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organ, replacing US Biomax 1206 |
FDA902b |
FDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organ, replacing |
US Biomax |
|
1206€ |
|
Pub |
FDA902-2 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, 15 cases 45 cores, replaced by FDA902b-2; ihc Anti-Actin confirmed US Biomax 858 |
FDA902-2 |
FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, 15 cases 45 cores, replaced by FDA902b-2; ihc Anti-Actin confirmed |
US Biomax |
|
858€ |
|
Pub |
FRA901a-1 Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-1; ihc Anti-Actin c US Biomax 626 |
FRA901a-1 |
Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-1; ihc Anti-Actin c |
US Biomax |
|
626€ |
|
Pub |
FRA901a-2 Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-2; ihc Anti-Actin c US Biomax 626 |
FRA901a-2 |
Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-2; ihc Anti-Actin c |
US Biomax |
|
626€ |
|
Pub |
FMO901-2 Normal mouse multiple organ frozen tissue array, for therapeutic and diagnostic antibody, 15 organs 45 cores, slide 2 of 2 tissue arrays; ihc Anti-Actin confirmed US Biomax 626 |
FMO901-2 |
Normal mouse multiple organ frozen tissue array, for therapeutic and diagnostic antibody, 15 organs 45 cores, slide 2 of 2 tissue arrays; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
FRA901a Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation, 45 cases 45 cores, 2 slides set, replacing FRA901; ihc Anti-Actin confirmed US Biomax 858 |
FRA901a |
Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation, 45 cases 45 cores, 2 slides set, replacing FRA901; ihc Anti-Actin confirmed |
US Biomax |
|
858€ |
|
Pub |
FRA781-1 FDA standard normal rat multiple organ frozen tissue array, slide one, 26 cases 78 cores; ihc Anti-Actin confirmed US Biomax 626 |
FRA781-1 |
FDA standard normal rat multiple organ frozen tissue array, slide one, 26 cases 78 cores; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
FRA781-2 FDA standard normal rat multiple organ frozen tissue array, slide two, 26 cases 78 cores; ihc Anti-Actin confirmed US Biomax 626 |
FRA781-2 |
FDA standard normal rat multiple organ frozen tissue array, slide two, 26 cases 78 cores; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
FRA901-1 FDA standard normal rat multiple organ frozen tissue array, slide one, 15 cases 45 cores, replaced by FRA901a-1; ihc Anti-Actin confirmed US Biomax 626 |
FRA901-1 |
FDA standard normal rat multiple organ frozen tissue array, slide one, 15 cases 45 cores, replaced by FRA901a-1; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
CyFDA1 FDA multiple organ normal tissue array of cynomolgus monkey, 34 organs 99 cores, replacing CyFDA; ihc Anti-Actin confirmed US Biomax 296 |
CyFDA1 |
FDA multiple organ normal tissue array of cynomolgus monkey, 34 organs 99 cores, replacing CyFDA; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
FFE302a Multiple organ normal frozen tissue array, 15 organs 30 cores; ihc Anti-Actin confirmed US Biomax 394 |
FFE302a |
Multiple organ normal frozen tissue array, 15 organs 30 cores; ihc Anti-Actin confirmed |
US Biomax |
|
394€ |
|
Pub |
FRA901-2 Normal rat multiple organ (recommended by FDA) frozen tissue array, slide two, 15 cases 45 cores, replaced by FRA901a-2; ihc Anti-Actin confirmed US Biomax 626 |
FRA901-2 |
Normal rat multiple organ (recommended by FDA) frozen tissue array, slide two, 15 cases 45 cores, replaced by FRA901a-2; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
FDA807 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA806, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296 |
FDA807 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA806, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
FDA808 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA807, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296 |
FDA808 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA807, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
FDA808a FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA808, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296 |
FDA808a |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA808, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
FDA808a-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing FDA808-2; ihc Anti-Actin confirmed US Biomax 267 |
FDA808a-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing FDA808-2; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
FBN401 Normal human multiple organ frozen tissue array (20 organs in duplicate), 20 cases 40 cores; ihc Anti-Actin confirmed US Biomax 278 |
FBN401 |
Normal human multiple organ frozen tissue array (20 organs in duplicate), 20 cases 40 cores; ihc Anti-Actin confirmed |
US Biomax |
|
278€ |
|
Pub |
FBN406a Multiple organ normal frozen tissue array, 20 organs 40 cores; ihc Anti-Actin confirmed US Biomax 394 |
FBN406a |
Multiple organ normal frozen tissue array, 20 organs 40 cores; ihc Anti-Actin confirmed |
US Biomax |
|
394€ |
|
Pub |
FDA808a-1 Multiple organ normal tissue array, 72 cases 72 cores, replacing FDA808-1; ihc Anti-Actin confirmed US Biomax 267 |
FDA808a-1 |
Multiple organ normal tissue array, 72 cases 72 cores, replacing FDA808-1; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
FDA999a Multiple organ normal tissue array, 47 cases 99 cores, replacing FDA999; ihc Anti-Actin confirmed US Biomax 296 |
FDA999a |
Multiple organ normal tissue array, 47 cases 99 cores, replacing FDA999; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
FMO901 FDA standard normal mouse multiple organ frozen tissue array, slide one, 15 organs 45 cores US Biomax 293 |
FMO901 |
FDA standard normal mouse multiple organ frozen tissue array, slide one, 15 organs 45 cores |
US Biomax |
|
293€ |
|
Pub |
FRB901 FDA standard normal rabbit multiple organ frozen tissue array, slide one, 15 organs 45 cores US Biomax 331 |
FRB901 |
FDA standard normal rabbit multiple organ frozen tissue array, slide one, 15 organs 45 cores |
US Biomax |
|
331€ |
|
Pub |
FBN407a Multiple organ normal frozen tissue array, 20 cases 40 cores, replaing FBN407; ihc Anti-Actin confirmed US Biomax 626 |
FBN407a |
Multiple organ normal frozen tissue array, 20 cases 40 cores, replaing FBN407; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
FMC282a Multiple organ cancer frozen tissue array, including pathology grade, 28 cases 28 cores, replacing FMC282; ihc Anti-Actin confirmed US Biomax 394 |
FMC282a |
Multiple organ cancer frozen tissue array, including pathology grade, 28 cases 28 cores, replacing FMC282; ihc Anti-Actin confirmed |
US Biomax |
|
394€ |
|
Pub |
FMC402a Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replaced by FMC402b; ihc Anti-Actin confirmed US Biomax 626 |
FMC402a |
Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replaced by FMC402b; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
FMC402b Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replacing FMC402a; ihc Anti-Actin confirmed US Biomax 626 |
FMC402b |
Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replacing FMC402a; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
FMC405a Multiple organ cancer frozen tissue array, including pathology grade, 40 cases 40 cores, replacing FMC405; ihc Anti-Actin confirmed US Biomax 626 |
FMC405a |
Multiple organ cancer frozen tissue array, including pathology grade, 40 cases 40 cores, replacing FMC405; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
FMC406c Frozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases 40 cores; ihc Anti-Actin confirmed US Biomax 626 |
FMC406c |
Frozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases 40 cores; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
FMC407b Multiple organ cancer frozen tissue array, including TNM information, 40 cases 40 cores, replacing FMC407; ihc Anti-Actin confirmed US Biomax 626 |
FMC407b |
Multiple organ cancer frozen tissue array, including TNM information, 40 cases 40 cores, replacing FMC407; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
FMC409a Frozen multiple organ cancer tissue array, 20 cases 40 cores, replacing FMC409; ihc Anti-Actin confirmed US Biomax 626 |
FMC409a |
Frozen multiple organ cancer tissue array, 20 cases 40 cores, replacing FMC409; ihc Anti-Actin confirmed |
US Biomax |
|
626€ |
|
Pub |
FMO721 FDA standard normal mouse multiple organ frozen tissue array, two slides, 24 cases 72 cores US Biomax 293 |
FMO721 |
FDA standard normal mouse multiple organ frozen tissue array, two slides, 24 cases 72 cores |
US Biomax |
|
293€ |
|
Pub |
FRA781 FDA standard normal rat multiple organ frozen tissue array, two slides, 26 cases 78 cores US Biomax 331 |
FRA781 |
FDA standard normal rat multiple organ frozen tissue array, two slides, 26 cases 78 cores |
US Biomax |
|
331€ |
|
Pub |
BC01071a Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing BC01071; ihc Anti-Actin confirmed US Biomax 185 |
BC01071a |
Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing BC01071; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
BCN963a Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 81 cases 96 cores, replacing BCN963; ihc Anti-Actin confirmed US Biomax 258 |
BCN963a |
Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 81 cases 96 cores, replacing BCN963; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
BN1002a Multiple organ normal tissue array, 100 cases 100 cores, replacing BN1002; ihc Anti-Actin confirmed US Biomax 296 |
BN1002a |
Multiple organ normal tissue array, 100 cases 100 cores, replacing BN1002; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
BN243a Multiple organ normal tissue array, 12 cases 24 cores, replacing BN243; ihc Anti-Actin confirmed US Biomax 105 |
BN243a |
Multiple organ normal tissue array, 12 cases 24 cores, replacing BN243; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
BRF401 Breast cancer frozen tissue array, with normal tissue, 40 cases 40 cores, Her-2 and ER PR IHC are supplied when purchase; ihc Anti-Actin confirmed US Biomax 742 |
BRF401 |
Breast cancer frozen tissue array, with normal tissue, 40 cases 40 cores, Her-2 and ER PR IHC are supplied when purchase; ihc Anti-Actin confirmed |
US Biomax |
|
742€ |
|
Pub |
FFE301 Human normal fetal frozen tissue array, total of 15 major organs from one case, 15 organs 30 cores, replaced by FFE302 US Biomax 199 |
FFE301 |
Human normal fetal frozen tissue array, total of 15 major organs from one case, 15 organs 30 cores, replaced by FFE302 |
US Biomax |
|
199€ |
|
Pub |
FMC281 Multiple tumor and corresponding normal frozen tissue (14 types) array, 14 cases 28 cores, previously named FMC401; ihc Anti-Actin confirmed US Biomax 394 |
FMC281 |
Multiple tumor and corresponding normal frozen tissue (14 types) array, 14 cases 28 cores, previously named FMC401; ihc Anti-Actin confirmed |
US Biomax |
|
394€ |
|
Pub |
FRA901 Normal rat multiple organ (recommended by FDA) frozen tissue array, slide one, 15 cases 45 cores US Biomax 331 |
FRA901 |
Normal rat multiple organ (recommended by FDA) frozen tissue array, slide one, 15 cases 45 cores |
US Biomax |
|
331€ |
|
Pub |
MBN481 Multiple organ normal tissue array, 48 cases 48 cores; ihc Anti-Actin confirmed US Biomax 185 |
MBN481 |
Multiple organ normal tissue array, 48 cases 48 cores; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
MC246 Multiple organ tumor with matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC244; ihc Anti-Actin confirmed US Biomax 90 |
MC246 |
Multiple organ tumor with matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC244; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
MC6163 High-density tissue array of multiple organ tumor and normal tissue, with pathology grade, cllinical stage and TNM, 616 cases 616 cores; ihc Anti-Actin confirmed US Biomax 811 |
MC6163 |
High-density tissue array of multiple organ tumor and normal tissue, with pathology grade, cllinical stage and TNM, 616 cases 616 cores; ihc Anti-Actin confirmed |
US Biomax |
|
811€ |
|
Pub |
MC803a Multiple organ tumor tissue array with adjacent normal tissue, including TNM and clinical stage, 40 cases 80 cores, replacing MC803; ihc Anti-Actin confirmed US Biomax 320 |
MC803a |
Multiple organ tumor tissue array with adjacent normal tissue, including TNM and clinical stage, 40 cases 80 cores, replacing MC803; ihc Anti-Actin confirmed |
US Biomax |
|
320€ |
|
Pub |
MO541 Mouse multiple organ normal tissue array, 24 cases 54 cores; ihc Anti-Actin confirmed US Biomax 162 |
MO541 |
Mouse multiple organ normal tissue array, 24 cases 54 cores; ihc Anti-Actin confirmed |
US Biomax |
|
162€ |
|
Pub |
PRF281 Prostate cancer frozen tissue array, with grade and Gleason scores and normal prostate tissue control, 28 cases 28 cores; ihc H&E and Anti-Actin confirmed US Biomax 742.35 |
PRF281 |
Prostate cancer frozen tissue array, with grade and Gleason scores and normal prostate tissue control, 28 cases 28 cores; ihc H&E and Anti-Actin confirmed |
US Biomax |
|
742.35€ |
|
Pub |
SO751 Leiomyosarcoma and rhabdomyosarcoma tissue array, including TNM and clinical stage, 39 cases 75 cores, replacing BC24021; ihc Anti-Actin confirmed US Biomax 267 |
SO751 |
Leiomyosarcoma and rhabdomyosarcoma tissue array, including TNM and clinical stage, 39 cases 75 cores, replacing BC24021; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
BC041115a Lung cancer tissue array with normal lung tissue, including TNM, clinical stage and pathology grade, 120 cases 120 cores, replacing BC041115; ihc Anti-Actin confirmed US Biomax 296 |
BC041115a |
Lung cancer tissue array with normal lung tissue, including TNM, clinical stage and pathology grade, 120 cases 120 cores, replacing BC041115; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
BC05118a Colon cancer tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BC05118; ihc Anti-Actin confirmed US Biomax 296 |
BC05118a |
Colon cancer tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BC05118; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
BC07014a Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC07014; ihc Anti-Actin confirmed US Biomax 185 |
BC07014a |
Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC07014; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
BC11012a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC11012; ihc Anti-Actin confirmed US Biomax 185 |
BC11012a |
Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC11012; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
BC12011a Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing BC12011; ihc Anti-Actin confirmed US Biomax 162 |
BC12011a |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing BC12011; ihc Anti-Actin confirmed |
US Biomax |
|
162€ |
|
Pub |
BL1501 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
BL1501 |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
BL244 Bladder cancer tissue array with matched adjacent bladder tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105 |
BL244 |
Bladder cancer tissue array with matched adjacent bladder tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
BO244a Human normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105 |
BO244a |
Human normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
BR1005a Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BR1005; ihc Anti-Actin confirmed US Biomax 296 |
BR1005a |
Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BR1005; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
BR243b Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243; ihc Anti-Actin confirmed US Biomax 90 |
BR243b |
Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases 24 cores, replacing BR243; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BR243c Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by BR243d; ihc Anti-Actin confirmed US Biomax 90 |
BR243c |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replaced by BR243d; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BR243d Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243c; ihc Anti-Actin confirmed US Biomax 90 |
BR243d |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243c; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BR243e Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed US Biomax 90 |
BR243e |
Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BR243f Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed US Biomax 90 |
BR243f |
Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing BR243a; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
BR803a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmed US Biomax 258 |
BR803a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
BR804a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR804; ihc Anti-Actin confirmed US Biomax 267 |
BR804a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR804; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
BR963a Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmed US Biomax 296 |
BR963a |
Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
BR964 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 |
BR964 |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
228€ |
|
Pub |
BRN801a Breast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BRN801; ihc Anti-Actin confirmed US Biomax 258 |
BRN801a |
Breast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BRN801; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
BS17016a Brain glioblastoma tissue array, including pathology grade, 40 cases 80 cores, replacing BS17016; ihc Anti-Actin confirmed US Biomax 267 |
BS17016a |
Brain glioblastoma tissue array, including pathology grade, 40 cases 80 cores, replacing BS17016; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
CO1021 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed US Biomax 296 |
CO1021 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
CO1502 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
CO1502 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
CO241a Colon cancer tissue array with adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing CO241; ihc Anti-Actin confirmed US Biomax 105 |
CO241a |
Colon cancer tissue array with adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 6 cases 24 cores, replacing CO241; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
CO242a Colon carcinoma tissue array with adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO242; ihc Anti-Actin confirmed US Biomax 81 |
CO242a |
Colon carcinoma tissue array with adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO242; ihc Anti-Actin confirmed |
US Biomax |
|
81€ |
|
Pub |
CO243a Colon carcinoma tissue array with matched adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO243; ihc Anti-Actin confirmed US Biomax 105 |
CO243a |
Colon carcinoma tissue array with matched adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing CO243; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
CO484a Colon cancer tissue array with adjacent normal tissues, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing CO484; ihc Anti-Actin confirmed US Biomax 210 |
CO484a |
Colon cancer tissue array with adjacent normal tissues, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing CO484; ihc Anti-Actin confirmed |
US Biomax |
|
210€ |
|
Pub |
CO488 Colon adenocarcinoma with matched adjacent colon tissue array, including TNM, clinical stage and pathology grade, 16 cases 48 cores; ihc Anti-Actin confirmed US Biomax 185 |
CO488 |
Colon adenocarcinoma with matched adjacent colon tissue array, including TNM, clinical stage and pathology grade, 16 cases 48 cores; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
CO802a Colon cancer tissue array with adjacent normal colon tissue, including TNM and clinical stage, 80 cases 80 cores, replacing CO802; ihc Anti-Actin confirmed US Biomax 258 |
CO802a |
Colon cancer tissue array with adjacent normal colon tissue, including TNM and clinical stage, 80 cases 80 cores, replacing CO802; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
CO804a Colon cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replcing CO804; ihc Anti-Actin confirmed US Biomax 267 |
CO804a |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replcing CO804; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
CO952 Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores, replacing CO951; ihc Anti-Cytokeratin (CK) confi US Biomax 429 |
CO952 |
Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores, replacing CO951; ihc Anti-Cytokeratin (CK) confi |
US Biomax |
|
429€ |
|
Pub |
CO962 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 |
CO962 |
Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
CR1501 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
CR1501 |
Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
CR245 Cervical cancer tissue array with matched adjacent cervical tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105 |
CR245 |
Cervical cancer tissue array with matched adjacent cervical tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
EN801a Endocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmed US Biomax 296 |
EN801a |
Endocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
ES1502 Esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
ES1502 |
Esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
ES244 Esophageal squamous cell carcinoma tissue array with matched adjacent esophageal tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
ES244 |
Esophageal squamous cell carcinoma tissue array with matched adjacent esophageal tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
ES481 Esophageal cancer tissue array with matched or unmatched normal adjacent tissues (18 cases 48 cores) with stage and grade info; ihc Anti-Actin confirmed US Biomax 210 |
ES481 |
Esophageal cancer tissue array with matched or unmatched normal adjacent tissues (18 cases 48 cores) with stage and grade info; ihc Anti-Actin confirmed |
US Biomax |
|
210€ |
|
Pub |
ES962 Esophageal squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 |
ES962 |
Esophageal squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
FDA801 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA802, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies. US Biomax 278 |
FDA801 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA802, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies. |
US Biomax |
|
278€ |
|
Pub |
FDA802 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA803, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies. US Biomax 278 |
FDA802 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA803, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies. |
US Biomax |
|
278€ |
|
Pub |
FDA803 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies. US Biomax 278 |
FDA803 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies. |
US Biomax |
|
278€ |
|
Pub |
FDA804 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies US Biomax 278 |
FDA804 |
FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies |
US Biomax |
|
278€ |
|
Pub |
FDA805 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies US Biomax 314 |
FDA805 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA804, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies |
US Biomax |
|
314€ |
|
Pub |
FDA806 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies US Biomax 380 |
FDA806 |
FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA805, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies |
US Biomax |
|
380€ |
|
Pub |
FDA807-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA806 2 US Biomax 336 |
FDA807-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA806 2 |
US Biomax |
|
336€ |
|
Pub |
FDA808-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA805 2 US Biomax 277 |
FDA808-2 |
Multiple organ tumor tissue array with adjacent normal human organs, including TNM and pathology grade, 72 cases 72 cores, replacing FDA805 2 |
US Biomax |
|
277€ |
|
Pub |
FDA994 FDA normal human organ tissue array, 99 cores 33 sites 75 cases, replacing FDA993, replaced by FDA995 US Biomax 314 |
FDA994 |
FDA normal human organ tissue array, 99 cores 33 sites 75 cases, replacing FDA993, replaced by FDA995 |
US Biomax |
|
314€ |
|
Pub |
FDA995 FDA normal human organ tissue array, 99 cores 33 sites 75 cases, replaced by FDA997 US Biomax 278 |
FDA995 |
FDA normal human organ tissue array, 99 cores 33 sites 75 cases, replaced by FDA997 |
US Biomax |
|
278€ |
|
Pub |
FFE302 Multiple organ normal frozen tissue array, 15 cases 30 cores, replacing FFE301 US Biomax 199 |
FFE302 |
Multiple organ normal frozen tissue array, 15 cases 30 cores, replacing FFE301 |
US Biomax |
|
199€ |
|
Pub |
GL241a Brain tumor tissue array with adjacent normal brain tissue, including pathology grade, 10 cases 24 cores, replacing GL241; ihc Anti-Actin confirmed US Biomax 90 |
GL241a |
Brain tumor tissue array with adjacent normal brain tissue, including pathology grade, 10 cases 24 cores, replacing GL241; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
GL803a Brain tumor and adjacent normal tissue array, including pathology grade, 80 cases 80 cores, replacing GL803; ihc Anti-Actin confirmed US Biomax 296 |
GL803a |
Brain tumor and adjacent normal tissue array, including pathology grade, 80 cases 80 cores, replacing GL803; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
GL806a Brain glioblastoma multiforme(GBM) tissue array, 40 cases 80 cores, replacing GL806; ihc Anti-Actin confirmed US Biomax 258 |
GL806a |
Brain glioblastoma multiforme(GBM) tissue array, 40 cases 80 cores, replacing GL806; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
HN241a Head and neck cancer tissue array with adjacent normal head and neck tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN241; ihc Anti-Actin confirmed US Biomax 90 |
HN241a |
Head and neck cancer tissue array with adjacent normal head and neck tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN241; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
HN242a Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN242; ihc Anti-Actin confirmed US Biomax 90 |
HN242a |
Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN242; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
HN803a Multiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing HN803; ihc Anti-Actin confirmed US Biomax 296 |
HN803a |
Multiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing HN803; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
KD1501 Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
KD1501 |
Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
KD244 Kidney clear cell carcinoma tissue array with matched kidney adjacent tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
KD244 |
Kidney clear cell carcinoma tissue array with matched kidney adjacent tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
KD961 Kidney tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 |
KD961 |
Kidney tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
LC10010a Lung carcinoma tissue array with normal lung tissue as control, including TNM and clinical stage, 50 cases 100 cores, replacing LC10010; ihc Anti-Actin confirmed US Biomax 296 |
LC10010a |
Lung carcinoma tissue array with normal lung tissue as control, including TNM and clinical stage, 50 cases 100 cores, replacing LC10010; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
LC1502 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
LC1502 |
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
LC488 Lung cancer tissue array with matched adjacent lung tissue, including TNM, clinical stage and pathology grade, 16 cases 48 cores; ihc Anti-Actin confirmed US Biomax 185 |
LC488 |
Lung cancer tissue array with matched adjacent lung tissue, including TNM, clinical stage and pathology grade, 16 cases 48 cores; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
LC726a Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing LC726; ihc Anti-Actin confirmed US Biomax 228 |
LC726a |
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing LC726; ihc Anti-Actin confirmed |
US Biomax |
|
228€ |
|
Pub |
LC817 Lung cancer tissue array with matched lymph node metastatic tissue, including TNM, clinical stage and pathology grade, 40 cases 80 cores; ihc Anti-Actin confirmed US Biomax 258 |
LC817 |
Lung cancer tissue array with matched lymph node metastatic tissue, including TNM, clinical stage and pathology grade, 40 cases 80 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
LC961 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 |
LC961 |
Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
LM482a Lymphoma tissue array with normal lymph node tissue as control, 48 cases 48 cores, replacing LM482; ihc Anti-Actin confirmed US Biomax 320 |
LM482a |
Lymphoma tissue array with normal lymph node tissue as control, 48 cases 48 cores, replacing LM482; ihc Anti-Actin confirmed |
US Biomax |
|
320€ |
|
Pub |
LM801a Lymphoma tissue array with adjacent normal lymph node and spleen tissue as control, 80 cases 80 cores, replacing LM801; ihc Anti-Actin confirmed US Biomax 267 |
LM801a |
Lymphoma tissue array with adjacent normal lymph node and spleen tissue as control, 80 cases 80 cores, replacing LM801; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
LV1502 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
LV1502 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
LV2091 Liver cancer tissue array with normal liver tissue as control, including TNM, clinical stage and pathology grade, 208 cases 208 cores; ihc Anti-Actin confirmed US Biomax 429 |
LV2091 |
Liver cancer tissue array with normal liver tissue as control, including TNM, clinical stage and pathology grade, 208 cases 208 cores; ihc Anti-Actin confirmed |
US Biomax |
|
429€ |
|
Pub |
LV487 Hepatocellular carcinoma tissue array with matched liver adjacent tissue, including TNM and pathology grade, 16 cases 48 cores,; ihc Anti-Actin confirmed US Biomax 185 |
LV487 |
Hepatocellular carcinoma tissue array with matched liver adjacent tissue, including TNM and pathology grade, 16 cases 48 cores,; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
LV8010 Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011; ihc Anti-Actin confirmed US Biomax 296 |
LV8010 |
Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
LV962 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 |
LV962 |
Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
LY1001a Diffuse large-B cell lymphoma tissue array, 100 cases 100 cores, replacing LY1001; ihc Anti-Actin confirmed US Biomax 296 |
LY1001a |
Diffuse large-B cell lymphoma tissue array, 100 cases 100 cores, replacing LY1001; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
LY121a Diffuse large B-cell lymphoma tissue array, 12 cases 12 cores, replacing LY121; ihc Anti-Actin confirmed US Biomax 185 |
LY121a |
Diffuse large B-cell lymphoma tissue array, 12 cases 12 cores, replacing LY121; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
MC809a Blastoma tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing MC809; ihc Anti-Actin confirmed US Biomax 382 |
MC809a |
Blastoma tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing MC809; ihc Anti-Actin confirmed |
US Biomax |
|
382€ |
|
Pub |
ME1004a Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replacing ME1004; ihc Anti-Actin confirmed US Biomax 296 |
ME1004a |
Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replacing ME1004; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
ME2082a Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores, replacing ME2082; ihc Anti-Actin confirmed US Biomax 429 |
ME2082a |
Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores, replacing ME2082; ihc Anti-Actin confirmed |
US Biomax |
|
429€ |
|
Pub |
ME241a Multiple malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 12 cases 24 cores, replacing ME241; ihc Anti-Actin confirmed US Biomax 105 |
ME241a |
Multiple malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 12 cases 24 cores, replacing ME241; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
ME481a Melanoma tissue array with normal skin tissues, including TNM and clinical stage, 48 cases 48 cores, replacing ME481; ihc Anti-Actin confirmed US Biomax 185 |
ME481a |
Melanoma tissue array with normal skin tissues, including TNM and clinical stage, 48 cases 48 cores, replacing ME481; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
ME803a Malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 80 cases 80 cores, replacing ME803; ihc Anti-Actin confirmed US Biomax 296 |
ME803a |
Malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 80 cases 80 cores, replacing ME803; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
MS481a Mesothelioma tissue array with normal tissue as control, including TNM and clinical stage, 24 cases 48 cores, replacing MS481; ihc Anti-Actin confirmed US Biomax 296 |
MS481a |
Mesothelioma tissue array with normal tissue as control, including TNM and clinical stage, 24 cases 48 cores, replacing MS481; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
NHL401a Lymphoma, myeloma and lymph node tissue array, 40 cases 40 cores, replacing NHL401; ihc Anti-Actin confirmed US Biomax 296 |
NHL401a |
Lymphoma, myeloma and lymph node tissue array, 40 cases 40 cores, replacing NHL401; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
NHL802a Non-Hodgkin's lymphoma tissue array, 42 cases 80 cores, replacing NHL802; ihc Anti-Actin confirmed US Biomax 267 |
NHL802a |
Non-Hodgkin's lymphoma tissue array, 42 cases 80 cores, replacing NHL802; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
ON481 Oncocytoma tissue array, 24 cases 48 cores; ihc Anti-Actin confirmed US Biomax 162 |
ON481 |
Oncocytoma tissue array, 24 cases 48 cores; ihc Anti-Actin confirmed |
US Biomax |
|
162€ |
|
Pub |
OR601a Oral squamous cell cancer tissue array with adjacent normal tongue tissue, including TNM, clinical stage and pathology grade, 60 cases 60 cores, replacing OR601; ihc Anti-Actin confirmed US Biomax 258 |
OR601a |
Oral squamous cell cancer tissue array with adjacent normal tongue tissue, including TNM, clinical stage and pathology grade, 60 cases 60 cores, replacing OR601; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
OV1005a Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1005; ihc Anti-Actin confirmed US Biomax 267 |
OV1005a |
Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1005; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
OV241a Ovary cancer and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing OV241; ihc Anti-Actin confirmed US Biomax 105 |
OV241a |
Ovary cancer and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing OV241; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
OV701 Ovary cancer tissue array, with adjacent normal tissue, including TNM, clinical stage and pathology grade, 70 cases 70 cores, replacing BC111110; ihc Anti-Actin confirmed US Biomax 228 |
OV701 |
Ovary cancer tissue array, with adjacent normal tissue, including TNM, clinical stage and pathology grade, 70 cases 70 cores, replacing BC111110; ihc Anti-Actin confirmed |
US Biomax |
|
228€ |
|
Pub |
OV803a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing OV803; ihc Anti-Actin confirmed US Biomax 258 |
OV803a |
Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing OV803; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
OV961 Ovary tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 |
OV961 |
Ovary tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
228€ |
|
Pub |
PA242a Pancreas cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PA242; ihc Anti-Actin confirmed US Biomax 105 |
PA242a |
Pancreas cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PA242; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
PA483a Pancreatic cancer tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing PA483; ihc Anti-Actin confirmed US Biomax 185 |
PA483a |
Pancreatic cancer tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing PA483; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
PA805a Pancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PA805; ihc Anti-Actin confirmed US Biomax 296 |
PA805a |
Pancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PA805; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
PA961a Pancreatic cancer tissue array with normal pancreatic tissue, including TNM, clinical stage and pathology grade, 96 cases 96 cores, replacing PA961; ihc Anti-Actin confirmed US Biomax 258 |
PA961a |
Pancreatic cancer tissue array with normal pancreatic tissue, including TNM, clinical stage and pathology grade, 96 cases 96 cores, replacing PA961; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
PM2-ER ER Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer and IHC results of ER Ki67 PR Her-2, 10 cases 10 cores; ihc Anti-Actin confirmed US Biomax 114 |
PM2-ER |
ER Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer and IHC results of ER Ki67 PR Her-2, 10 cases 10 cores; ihc Anti-Actin confirmed |
US Biomax |
|
114€ |
|
Pub |
PR242a Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR242; ihc Anti-Actin confirmed US Biomax 105 |
PR242a |
Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR242; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
PR243a Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR243; ihc Anti-Actin confirmed US Biomax 105 |
PR243a |
Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PR243; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
PR483a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing PR483; ihc Anti-Actin confirmed US Biomax 210 |
PR483a |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing PR483; ihc Anti-Actin confirmed |
US Biomax |
|
210€ |
|
Pub |
PR484 Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores; ihc Anti-Actin confirmed US Biomax 162 |
PR484 |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores; ihc Anti-Actin confirmed |
US Biomax |
|
162€ |
|
Pub |
PR633 Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing PR8010; ihc Anti-Actin confirmed US Biomax 296 |
PR633 |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing PR8010; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
PR803a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PR803; ihc Anti-Actin confirmed US Biomax 296 |
PR803a |
Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PR803; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
RE1021 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed US Biomax 296 |
RE1021 |
Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
RE1503 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
RE1503 |
Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
SF961 Soft tissue tumor tissue array, including TNM and clinical stage, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 |
SF961 |
Soft tissue tumor tissue array, including TNM and clinical stage, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
228€ |
|
Pub |
SK245 Skin disease tissue array, including TNM, clinical stage and pathology grade, 24 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105 |
SK245 |
Skin disease tissue array, including TNM, clinical stage and pathology grade, 24 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
SK961 Skin tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 |
SK961 |
Skin tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
ST1004 Stomach adenocarcinoma with matched adjacent tissue array, including TNM and pathology grade, 55 cases 100 cores, replacing BC01114; ihc Anti-Actin confirmed US Biomax 258 |
ST1004 |
Stomach adenocarcinoma with matched adjacent tissue array, including TNM and pathology grade, 55 cases 100 cores, replacing BC01114; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
ST1503 Stomach adenocarcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
ST1503 |
Stomach adenocarcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
ST2091 Stomach cancer tissue array with adjacent normal stomach tissue, including TNM and clinical stage, 208 cases 208 cores, replacing ST2001; ihc Anti-Actin confirmed US Biomax 487 |
ST2091 |
Stomach cancer tissue array with adjacent normal stomach tissue, including TNM and clinical stage, 208 cases 208 cores, replacing ST2001; ihc Anti-Actin confirmed |
US Biomax |
|
487€ |
|
Pub |
ST483a Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed US Biomax 185 |
ST483a |
Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed |
US Biomax |
|
185€ |
|
Pub |
ST483b Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed US Biomax 210 |
ST483b |
Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed |
US Biomax |
|
210€ |
|
Pub |
ST801a Stomach cancer tissue array with matched adjacent normal stomach tissue, including TNM and clinical stage, 40 cases 80 cores, replacing ST801; ihc Anti-Actin confirmed US Biomax 267 |
ST801a |
Stomach cancer tissue array with matched adjacent normal stomach tissue, including TNM and clinical stage, 40 cases 80 cores, replacing ST801; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
ST962 Stomach cancer tissue array, including clinical stage, TNM and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 |
ST962 |
Stomach cancer tissue array, including clinical stage, TNM and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
228€ |
|
Pub |
T001a Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T001; ihc Anti-Actin confirmed US Biomax 90 |
T001a |
Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T001; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T014 Stomach cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T014 |
Stomach cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T024 Esophageal cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T024 |
Esophageal cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T032a Liver tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T032; ihc Anti-Actin confirmed US Biomax 90 |
T032a |
Liver tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T032; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T034 Liver cancer test tissue array (4x (2x3) array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T034 |
Liver cancer test tissue array (4x (2x3) array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T045c Lung cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T045; ihc Anti-Actin confirmed US Biomax 90 |
T045c |
Lung cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T045; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T046 Lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T046 |
Lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T047 Non-small cell lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T047 |
Non-small cell lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T054a Colon cancer tissue array with normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T054; ihc Anti-Actin confirmed US Biomax 90 |
T054a |
Colon cancer tissue array with normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T054; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T074 Kidney cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T074 |
Kidney cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T086a Breast invasive ductal carcinoma test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T086b; ihc Anti-Actin confirmed US Biomax 90 |
T086a |
Breast invasive ductal carcinoma test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T086b; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T086b Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T086a; ihc Anti-Actin confirmed US Biomax 90 |
T086b |
Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T086a; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T087a Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T087; ihc Anti-Actin confirmed US Biomax 90 |
T087a |
Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T087; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T089 Breast cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T089 |
Breast cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T095 Endometrium cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T095 |
Endometrium cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T104 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T104 |
Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T112a Ovary cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T112; ihc Anti-Actin confirmed US Biomax 90 |
T112a |
Ovary cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T112; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T113a Ovary cancer test tissue array with normal ovary tissue, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T113; ihc Anti-Actin confirmed US Biomax 90 |
T113a |
Ovary cancer test tissue array with normal ovary tissue, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T113; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T124 Bladder cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T122; ihc Anti-Actin confirmed US Biomax 90 |
T124 |
Bladder cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T122; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T125 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T125 |
Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T141a Pancreas cancer test tissue array, including TNM and pathology grade, 6 cases 24 cores, replacing T141; ihc Anti-Actin confirmed US Biomax 90 |
T141a |
Pancreas cancer test tissue array, including TNM and pathology grade, 6 cases 24 cores, replacing T141; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T142a Pancreas tumor test tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing T142; ihc Anti-Actin confirmed US Biomax 90 |
T142a |
Pancreas tumor test tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing T142; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T144 Pancreas cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T144 |
Pancreas cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T173a Brain cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T173; ihc Anti-Actin confirmed US Biomax 90 |
T173a |
Brain cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T173; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T174a Brain tumor tissue array with normal brain tissue as control, including pathology grade, 6 cases 24 cores, replacing T171; ihc Anti-Actin confirmed US Biomax 90 |
T174a |
Brain tumor tissue array with normal brain tissue as control, including pathology grade, 6 cases 24 cores, replacing T171; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T175 Brain tumor tissue array with normal brain tissue as control, including pathology grade, 12 cases 24 cores, replacing T172; ihc Anti-Actin confirmed US Biomax 105 |
T175 |
Brain tumor tissue array with normal brain tissue as control, including pathology grade, 12 cases 24 cores, replacing T172; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
T176 Brain tumor tissue array, including pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T176 |
Brain tumor tissue array, including pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T195a Prostate cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T195; ihc Anti-Actin confirmed US Biomax 105 |
T195a |
Prostate cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T195; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
T203a Lymphatic tissue tumor test tissue array, with normal control tissue, 12 cases 24 cores, replacing T203; ihc Anti-Actin confirmed US Biomax 90 |
T203a |
Lymphatic tissue tumor test tissue array, with normal control tissue, 12 cases 24 cores, replacing T203; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T205 Lymphoma tissue array, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T205 |
Lymphoma tissue array, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T212a Skin tumor tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T212; ihc Anti-Actin confirmed US Biomax 90 |
T212a |
Skin tumor tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T212; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T214 Skin tumor tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T214 |
Skin tumor tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T231a Testis tumor tissue array with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T231; ihc Anti-Actin confirmed US Biomax 90 |
T231a |
Testis tumor tissue array with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T231; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T244 Soft tissue malignant tumor tissue array, including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T244 |
Soft tissue malignant tumor tissue array, including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T343 Head & Neck cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T343 |
Head & Neck cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T385a Malignant melanoma test tissue array, including TNM and clinical stage, 6 cases 24 cores, replacing T385; ihc Anti-Actin confirmed US Biomax 90 |
T385a |
Malignant melanoma test tissue array, including TNM and clinical stage, 6 cases 24 cores, replacing T385; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
T388 Malignant melanoma test tissue array (4x (2x3)array), including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
T388 |
Malignant melanoma test tissue array (4x (2x3)array), including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
TH242 Thyroid cancer tissue array with matched adjacent thyroid tissue, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
TH242 |
Thyroid cancer tissue array with matched adjacent thyroid tissue, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
TH802a Thyroid cancer and adenoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing TH802; ihc Anti-Actin confirmed US Biomax 267 |
TH802a |
Thyroid cancer and adenoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing TH802; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
TH809a Thyroid metastatic carcinoma tissue array with normal thyroid tissue as control, 40 cases 80 cores, replacing TH809; ihc Anti-Actin confirmed US Biomax 296 |
TH809a |
Thyroid metastatic carcinoma tissue array with normal thyroid tissue as control, 40 cases 80 cores, replacing TH809; ihc Anti-Actin confirmed |
US Biomax |
|
296€ |
|
Pub |
UT1501 Uterus cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 |
UT1501 |
Uterus cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed |
US Biomax |
|
258€ |
|
Pub |
UT243 Endometrium cancer tissue array with matched adjacent endometrium tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 |
UT243 |
Endometrium cancer tissue array with matched adjacent endometrium tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed |
US Biomax |
|
90€ |
|
Pub |
UT961 Endometrium cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 |
UT961 |
Endometrium cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed |
US Biomax |
|
228€ |
|
Pub |
VLC12 Lung cancer tissue array, with TNM and grade info, 12 cases 12 cores; ihc Anti-Actin confirmed US Biomax 105 |
VLC12 |
Lung cancer tissue array, with TNM and grade info, 12 cases 12 cores; ihc Anti-Actin confirmed |
US Biomax |
|
105€ |
|
Pub |
AA0100 Angiogenesis (Human) Quantitative Antibody Array 2 is a multiplex antibody array for the quantitative measurement of 30 human angiogenic factors in 8-10 samples. Abnova 16 Arrays/Slide 1416 |
AA0100 |
Angiogenesis (Human) Quantitative Antibody Array 2 is a multiplex antibody array for the quantitative measurement of 30 human angiogenic factors in 8-10 samples. |
Abnova |
16 Arrays/Slide |
1416€ |
|
Pub |
AA0101 Angiogenesis (Human) Quantitative Antibody Array 3 is a multiplex antibody array for the quantitative measurement of 30 human angiogenic factors in 8-10 samples. Abnova 16 Arrays/Slide 1416 |
AA0101 |
Angiogenesis (Human) Quantitative Antibody Array 3 is a multiplex antibody array for the quantitative measurement of 30 human angiogenic factors in 8-10 samples. |
Abnova |
16 Arrays/Slide |
1416€ |
|
Pub |
AAM-BLG-1-2 Mouse L-308 Array, Glass Slide (2) Antibody Arrays High-Density Screening Arrays Ray Biotech 2 Sample Kit 559 |
AAM-BLG-1-2 |
Mouse L-308 Array, Glass Slide (2) Antibody Arrays High-Density Screening Arrays |
Ray Biotech |
2 Sample Kit |
559€ |
|
Pub |
AAM-BLG-1-4 Mouse L-308 Array, Glass Slide (4) Antibody Arrays High-Density Screening Arrays Ray Biotech 4 Sample Kit 917 |
AAM-BLG-1-4 |
Mouse L-308 Array, Glass Slide (4) Antibody Arrays High-Density Screening Arrays |
Ray Biotech |
4 Sample Kit |
917€ |
|
Pub |
BC00012 Multiple organ diseased tissue array, 30 cases 60 cores, replaced by MC801 US Biomax 160 |
BC00012 |
Multiple organ diseased tissue array, 30 cases 60 cores, replaced by MC801 |
US Biomax |
|
160€ |
|
Pub |
BC03011 Liver carcinoma (multi-tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010; ihc Anti-PCNA confirmed US Biomax 185 |
BC03011 |
Liver carcinoma (multi-tissue combined panel) tissue array, 63 cases 63 cores, replaced by LV8010; ihc Anti-PCNA confirmed |
US Biomax |
|
185€ |
|
Pub |
BC04011 Lung cancer tissue array, including pathology grade, 23 cases 63 cores, replaced by LC721; ihc Anti-Cytokeratin (CK) confirmed US Biomax 185 |
BC04011 |
Lung cancer tissue array, including pathology grade, 23 cases 63 cores, replaced by LC721; ihc Anti-Cytokeratin (CK) confirmed |
US Biomax |
|
185€ |
|
Pub |
BR10010a Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases 100 cores, replacing BR10010; ihc Anti-Actin confirme US Biomax 296 |
BR10010a |
Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases 100 cores, replacing BR10010; ihc Anti-Actin confirme |
US Biomax |
|
296€ |
|
Pub |
BR1505 Breast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases 150 cores, no overlaps with BR1503 or BR1504; ihc Anti-Actin US Biomax 296 |
BR1505 |
Breast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases 150 cores, no overlaps with BR1503 or BR1504; ihc Anti-Actin |
US Biomax |
|
296€ |
|
Pub |
BRC51 Breast cancer tissue array BLOCK, Her-2 IHC marker; ihc Anti-Cytokeratin (CK) confirmed US Biomax 4878 |
BRC51 |
Breast cancer tissue array BLOCK, Her-2 IHC marker; ihc Anti-Cytokeratin (CK) confirmed |
US Biomax |
|
4878€ |
|
Pub |
CMA241a Human tumor cell array, 12 cell lines 24 cores, replacing CMA241; ihc Anti-Actin confirmed US Biomax 267 |
CMA241a |
Human tumor cell array, 12 cell lines 24 cores, replacing CMA241; ihc Anti-Actin confirmed |
US Biomax |
|
267€ |
|
Pub |
CyFDA FDA normal organ tissue array of cynomolgus monkey, 99 cases 99 cores US Biomax 314 |
CyFDA |
FDA normal organ tissue array of cynomolgus monkey, 99 cases 99 cores |
US Biomax |
|
314€ |
|
Pub |
FDA800 Multiple organ tumor tissue array, 72 cases of variety of cancers 72 cores, replacing FDA802 2 or FDA803 2 US Biomax 266 |
FDA800 |
Multiple organ tumor tissue array, 72 cases of variety of cancers 72 cores, replacing FDA802 2 or FDA803 2 |
US Biomax |
|
266€ |
|
Pub |
FDA805-2 Multiple organ cancer and 6 types of normal organ tissue array, including TNM and pathology grade, 72 cases 72 cores, replaced by FDA808 2 US Biomax 278 |
FDA805-2 |
Multiple organ cancer and 6 types of normal organ tissue array, including TNM and pathology grade, 72 cases 72 cores, replaced by FDA808 2 |
US Biomax |
|
278€ |
|
Pub |
FDA992 FDA normal organ tissue array of human tissue, 67cases 100 cores US Biomax 278 |
FDA992 |
FDA normal organ tissue array of human tissue, 67cases 100 cores |
US Biomax |
|
278€ |
|
Pub |
FDA993 FDA normal human organ tissue array, 67cases 100 cores, replaced by FDA995 US Biomax 278 |
FDA993 |
FDA normal human organ tissue array, 67cases 100 cores, replaced by FDA995 |
US Biomax |
|
278€ |
|
Pub |
FDA997 FDA normal organ tissue array of human, 47 cases 99 cores, for FDA guidelines to test tissue specificity of antibodies, replaced by FDA998 US Biomax 314 |
FDA997 |
FDA normal organ tissue array of human, 47 cases 99 cores, for FDA guidelines to test tissue specificity of antibodies, replaced by FDA998 |
US Biomax |
|
314€ |
|
Pub |
FDA998 FDA normal organ tissue array of human, 47 cases 99 cores, replaced by FDA999 US Biomax 314 |
FDA998 |
FDA normal organ tissue array of human, 47 cases 99 cores, replaced by FDA999 |
US Biomax |
|
314€ |
|
Pub |
FDA999 Multiple organ normal tissue array, 47 cases 99 cores, replacing FDA998 US Biomax 314 |
FDA999 |
Multiple organ normal tissue array, 47 cases 99 cores, replacing FDA998 |
US Biomax |
|
314€ |
|
Pub |
GL2083a Brain tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing GL2083; ihc Anti-Cytokeratin (CK) confirmed US Biomax 487 |
GL2083a |
Brain tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases 208 cores, replacing GL2083; ihc Anti-Cytokeratin (CK) confirmed |
US Biomax |
|
487€ |
|
Pub |
LV961 Hepatocellular carcinoma tissue array, including TNM and pathology grade, 48 cases 96 cores; ihc Anti-Cytokeratin (CK) confirmed US Biomax 228 |
LV961 |
Hepatocellular carcinoma tissue array, including TNM and pathology grade, 48 cases 96 cores; ihc Anti-Cytokeratin (CK) confirmed |
US Biomax |
|
228€ |
|
Pub |
PR807a Prostate cancer, hyperplasia and normal tissue array, including TNM and pathology grade, 79 cases 80 cores, replacing PR807; ihc Anti-Prostate Specific Antigen (PSA) confirmed US Biomax 296 |
PR807a |
Prostate cancer, hyperplasia and normal tissue array, including TNM and pathology grade, 79 cases 80 cores, replacing PR807; ihc Anti-Prostate Specific Antigen (PSA) confirmed |
US Biomax |
|
296€ |
|
Pub |
PR951 Prostate adenocarcinoma tissue array with matched normal adjacent tissue and metastatic bones, 40 cases 95 cores, with TNM and Gleason scores, replaced by PR952; ihc Anti-PCNA confirmed US Biomax 487 |
PR951 |
Prostate adenocarcinoma tissue array with matched normal adjacent tissue and metastatic bones, 40 cases 95 cores, with TNM and Gleason scores, replaced by PR952; ihc Anti-PCNA confirmed |
US Biomax |
|
487€ |
|
Pub |
PR956 Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replacing PR955; ihc Anti-Actin confir US Biomax 487 |
PR956 |
Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replacing PR955; ihc Anti-Actin confir |
US Biomax |
|
487€ |
|
Pub |
RhFDA1 FDA normal organ tissue array of rhesus monkey, 99 cases 99 cores US Biomax 278 |
RhFDA1 |
FDA normal organ tissue array of rhesus monkey, 99 cases 99 cores |
US Biomax |
|
278€ |
|
Pub |
RhFDA2 FDA normal organ tissue array (TMA) block of rhesus monkey, 99 cases 99 cores US Biomax 23184 |
RhFDA2 |
FDA normal organ tissue array (TMA) block of rhesus monkey, 99 cases 99 cores |
US Biomax |
|
23184€ |
|
Pub |
T291a Myeloma tissue array with normal tissue as control, 6 cases 24 cores, replacing T291; ihc Anti-actin US Biomax 114 |
T291a |
Myeloma tissue array with normal tissue as control, 6 cases 24 cores, replacing T291; ihc Anti-actin |
US Biomax |
|
114€ |
|
Pub |
0100-0483 MOUSE ANTI BOVINE ROTAVIRUS MR STRAIN, Product Type Monoclonal Antibody, Specificity ROTAVIRUS MR STRAIN, Target Species Viral, Host Mouse, Format Purified, Isotypes IgG2a, Applications E, Clon AbD Serotec 0.2 mg 338 |
0100-0483 |
MOUSE ANTI BOVINE ROTAVIRUS MR STRAIN, Product Type Monoclonal Antibody, Specificity ROTAVIRUS MR STRAIN, Target Species Viral, Host Mouse, Format Purified, Isotypes IgG2a, Applications E, Clon |
AbD Serotec |
0.2 mg |
338€ |
|
Pub |
1439-9359 MOUSE ANTI BORRELIA BURGDORFERI FLAGELLAR ANTIGEN, Product Type Monoclonal Antibody, Specificity BORRELIA BURGDORFERI FLAGELLAR ANTIGEN, Target Species Bacterial, Host Mouse, Format Purified, Iso AbD Serotec 0.2 mg 373.747 |
1439-9359 |
MOUSE ANTI BORRELIA BURGDORFERI FLAGELLAR ANTIGEN, Product Type Monoclonal Antibody, Specificity BORRELIA BURGDORFERI FLAGELLAR ANTIGEN, Target Species Bacterial, Host Mouse, Format Purified, Iso |
AbD Serotec |
0.2 mg |
373.747€ |
|
Pub |
23092 succinate-CoA ligase, ADP-forming, beta subunit precursor antibody Source Rabbit Polyconal Ab Species Human Application WB IHC IF SignalWay Antibody S.A.B 100ul 329 |
23092 |
succinate-CoA ligase, ADP-forming, beta subunit precursor antibody Source Rabbit Polyconal Ab Species Human Application WB IHC IF |
SignalWay Antibody S.A.B |
100ul |
329€ |
|
Pub |
300-09971 Anti CEL Monoclonal Antibody (KNH-30) Antibodies B-Bridge 50UG 1113 |
300-09971 |
Anti CEL Monoclonal Antibody (KNH-30) Antibodies |
B-Bridge |
50UG |
1113€ |
|
Pub |
300-09971 Anti CEL Monoclonal Antibody (KNH 30) B-Bridge 50UG 1235.14 |
300-09971 |
Anti CEL Monoclonal Antibody (KNH 30) |
B-Bridge |
50UG |
1235.14€ |
|
Pub |
300-09971 Anti CEL Monoclonal Antibody (KNH 30) CEL is known to generate from protein modification by methylglyoxal . Mclellan et al. demonstrated that plasma methylglyoxal, which is believed to be generate fro B-Bridge 50 UG 958.65 |
300-09971 |
Anti CEL Monoclonal Antibody (KNH 30) CEL is known to generate from protein modification by methylglyoxal . Mclellan et al. demonstrated that plasma methylglyoxal, which is believed to be generate fro |
B-Bridge |
50 UG |
958.65€ |
|
Pub |
4828-30-06 anti-BrdU antibody Trevigen 30 167 |
4828-30-06 |
anti-BrdU antibody |
Trevigen |
30 |
167€ |
|
Pub |
4828-30-06 anti BrdU antibody Trevigen 30 ul 203.7 |
4828-30-06 |
anti BrdU antibody |
Trevigen |
30 ul |
203.7€ |
|
Pub |
A609685 2-Amino-6-formylpteridin-4-one C7H5N5O2 CAS: 712-30-1 TRC 2.5 mg 284 |
A609685 |
2-Amino-6-formylpteridin-4-one C7H5N5O2 CAS: 712-30-1 |
TRC |
2.5 mg |
284€ |
|
Pub |
AA0054 Cytokine (Mouse) Antibody Array (G) includes 32 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 731 |
AA0054 |
Cytokine (Mouse) Antibody Array (G) includes 32 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
731€ |
|
Pub |
AA0056 Cytokine (Mouse) Antibody Array (G) includes 34 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 731 |
AA0056 |
Cytokine (Mouse) Antibody Array (G) includes 34 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
731€ |
|
Pub |
AA0060 Cytokine (Rat) Antibody Array (G) includes 34 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 731 |
AA0060 |
Cytokine (Rat) Antibody Array (G) includes 34 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
731€ |
|
Pub |
AA0064 Th1 Th2 Th17 (Human) Antibody Array (G) includes 34 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 731 |
AA0064 |
Th1 Th2 Th17 (Human) Antibody Array (G) includes 34 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
731€ |
|
Pub |
AAM-BLM-1-2 Mouse L-308 Array, Membrane (2) Antibody Arrays High-Density Screening Arrays Ray Biotech 2 Sample Kit 736 |
AAM-BLM-1-2 |
Mouse L-308 Array, Membrane (2) Antibody Arrays High-Density Screening Arrays |
Ray Biotech |
2 Sample Kit |
736€ |
|
Pub |
AAM-BLM-1-4 Mouse L-308 Array, Membrane (4) Antibody Arrays High-Density Screening Arrays Ray Biotech 4 Sample Kit 1257 |
AAM-BLM-1-4 |
Mouse L-308 Array, Membrane (4) Antibody Arrays High-Density Screening Arrays |
Ray Biotech |
4 Sample Kit |
1257€ |
|
Pub |
AHP1233 RABBIT ANTI GSK3 BETA (pSer9), Product Type Polyclonal Antibody, Specificity GSK3 BETA , Target Species Rat, Host Rabbit, Format Purified, Isotypes Polyclonal IgG, Applications WB*, Clone AbD Serotec 0.1 ml 468.3 |
AHP1233 |
RABBIT ANTI GSK3 BETA (pSer9), Product Type Polyclonal Antibody, Specificity GSK3 BETA , Target Species Rat, Host Rabbit, Format Purified, Isotypes Polyclonal IgG, Applications WB*, Clone |
AbD Serotec |
0.1 ml |
468.3€ |
|
Pub |
BC000111 Multiple organ cancer tissue array, 39 cases 39 cores US Biomax 189 |
BC000111 |
Multiple organ cancer tissue array, 39 cases 39 cores |
US Biomax |
|
189€ |
|
Pub |
BC00114 Multiple organ normal and diseased tissue array, 36 cases 60 cores US Biomax 231 |
BC00114 |
Multiple organ normal and diseased tissue array, 36 cases 60 cores |
US Biomax |
|
231€ |
|
Pub |
BC00119 Multiple organ diseased tissue array, 32 cases 32 cores, replaced by MC483 US Biomax 160 |
BC00119 |
Multiple organ diseased tissue array, 32 cases 32 cores, replaced by MC483 |
US Biomax |
|
160€ |
|
Pub |
BC00432 Multiple organ tumor and adjacent normal tissue array, 39 cases 43 cores US Biomax 160 |
BC00432 |
Multiple organ tumor and adjacent normal tissue array, 39 cases 43 cores |
US Biomax |
|
160€ |
|
Pub |
BC04119 Lung adenocarcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 30 cases 40 cores, replaced by BC04119b US Biomax 231 |
BC04119 |
Lung adenocarcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 30 cases 40 cores, replaced by BC04119b |
US Biomax |
|
231€ |
|
Pub |
BC04119b Lung adenocarcinoma tissue array with normal lung tissue, including TNM and pathology grade,30 cases 40 cores, replacing BC04119 US Biomax 336 |
BC04119b |
Lung adenocarcinoma tissue array with normal lung tissue, including TNM and pathology grade,30 cases 40 cores, replacing BC04119 |
US Biomax |
|
336€ |
|
Pub |
BC19111 Normal prostate tissue array, with prostate tumor and hyperplasia, 11 cases 30 cores US Biomax 160 |
BC19111 |
Normal prostate tissue array, with prostate tumor and hyperplasia, 11 cases 30 cores |
US Biomax |
|
160€ |
|
Pub |
BN08111 Breast hyperplasia and normal tissue array, 10 cases 30 cores US Biomax 231 |
BN08111 |
Breast hyperplasia and normal tissue array, 10 cases 30 cores |
US Biomax |
|
231€ |
|
Pub |
BO601 Bone giant cell tumor tissue array, 30 cases 60 cores US Biomax 231 |
BO601 |
Bone giant cell tumor tissue array, 30 cases 60 cores |
US Biomax |
|
231€ |
|
Pub |
BR1503a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases 150 cores, replacing BR1503; ihc Anti- US Biomax 296 |
BR1503a |
Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases 150 cores, replacing BR1503; ihc Anti- |
US Biomax |
|
296€ |
|
Pub |
BR951 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, to be replaced by BR95 US Biomax 456 |
BR951 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, to be replaced by BR95 |
US Biomax |
|
456€ |
|
Pub |
BR952 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores US Biomax 456 |
BR952 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores |
US Biomax |
|
456€ |
|
Pub |
BR953 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR952 US Biomax 456 |
BR953 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR952 |
US Biomax |
|
456€ |
|
Pub |
BR954 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR953; ihc US Biomax 429 |
BR954 |
Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER PR p53 IHC results and survival data, 31 cases 95 cores, replacing BR953; ihc |
US Biomax |
|
429€ |
|
Pub |
BRF404 Breast invasive ductal carcinoma forzen tissue array, 20 cases 40 cores US Biomax 167 |
BRF404 |
Breast invasive ductal carcinoma forzen tissue array, 20 cases 40 cores |
US Biomax |
|
167€ |
|
Pub |
bs-0061R-A350 Rabbit Anti-beta-Actin (Loading Control) Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 |
bs-0061R-A350 |
Rabbit Anti-beta-Actin (Loading Control) Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG |
Sepax |
100ug Lyophilized |
323€ |
|
Pub |
bs-6319R-PE Rabbit Anti-IL-1 Beta IL-1B Polyclonal Antibody, PE Conjugated , 30kDa; Isotype IgG; Reactivity GuineaPig , Rabbit , Pig , Dog , Sheep , Human , Mouse , Rat; Application Flow-Cyt(1 20-100), IF(1 50 Bioss 100ug Lyophilized 502 |
bs-6319R-PE |
Rabbit Anti-IL-1 Beta IL-1B Polyclonal Antibody, PE Conjugated , 30kDa; Isotype IgG; Reactivity GuineaPig , Rabbit , Pig , Dog , Sheep , Human , Mouse , Rat; Application Flow-Cyt(1 20-100), IF(1 50 |
Bioss |
100ug Lyophilized |
502€ |
|
Pub |
bs-6319R-PE-Cy3 Rabbit Anti-IL-1 Beta IL-1B Polyclonal Antibody, PE-Cy3 Conjugated , 30kDa; Isotype IgG; Reactivity GuineaPig , Rabbit , Pig , Dog , Sheep , Human , Mouse , Rat; Application Flow-Cyt(1 20-100), IF( Bioss 100ug Lyophilized 530 |
bs-6319R-PE-Cy3 |
Rabbit Anti-IL-1 Beta IL-1B Polyclonal Antibody, PE-Cy3 Conjugated , 30kDa; Isotype IgG; Reactivity GuineaPig , Rabbit , Pig , Dog , Sheep , Human , Mouse , Rat; Application Flow-Cyt(1 20-100), IF( |
Bioss |
100ug Lyophilized |
530€ |
|
Pub |
bs-6848R-A350 Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 |
bs-6848R-A350 |
Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG |
Sepax |
100ug Lyophilized |
323€ |
|
Pub |
bs-7654R-PE Rabbit Anti-TIP30 Polyclonal Antibody, PE Conjugated , 27-30kDa; Isotype IgG; Reactivity Human , Mouse , Rat , Bovine , Dog; Application Flow-Cyt(1 20-100), IF(1 50-200) Bioss 100ug Lyophilized 502 |
bs-7654R-PE |
Rabbit Anti-TIP30 Polyclonal Antibody, PE Conjugated , 27-30kDa; Isotype IgG; Reactivity Human , Mouse , Rat , Bovine , Dog; Application Flow-Cyt(1 20-100), IF(1 50-200) |
Bioss |
100ug Lyophilized |
502€ |
|
Pub |
bs-7654R-PE-Cy3 Rabbit Anti-TIP30 Polyclonal Antibody, PE-Cy3 Conjugated , 27-30kDa; Isotype IgG; Reactivity Human , Mouse , Rat , Bovine , Dog; Application Flow-Cyt(1 20-100), IF(1 50-200) Bioss 100ug Lyophilized 530 |
bs-7654R-PE-Cy3 |
Rabbit Anti-TIP30 Polyclonal Antibody, PE-Cy3 Conjugated , 27-30kDa; Isotype IgG; Reactivity Human , Mouse , Rat , Bovine , Dog; Application Flow-Cyt(1 20-100), IF(1 50-200) |
Bioss |
100ug Lyophilized |
530€ |
|
Pub |
BS09011 Uteral leiomyoma (hysteromyoma) tissue array, 30 cases 60 cores US Biomax 231 |
BS09011 |
Uteral leiomyoma (hysteromyoma) tissue array, 30 cases 60 cores |
US Biomax |
|
231€ |
|
Pub |
BS20011 Lymphoma tissue array, 30 cases 30 cores, replaced by NHL481 US Biomax 189 |
BS20011 |
Lymphoma tissue array, 30 cases 30 cores, replaced by NHL481 |
US Biomax |
|
189€ |
|
Pub |
CO951 Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores US Biomax 456 |
CO951 |
Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases 95 cores |
US Biomax |
|
456€ |
|
Pub |
ES722 Esophageal cancer and adjacent tissue array, with stage and grade info, 30 cases 72 cores, replacing BC02023 US Biomax 231 |
ES722 |
Esophageal cancer and adjacent tissue array, with stage and grade info, 30 cases 72 cores, replacing BC02023 |
US Biomax |
|
231€ |
|
Pub |
ESC242 Esophagus cancer tissue array, 12 cases 24 cores; ihc H&E, IHC anti-Cytokeratin US Biomax 205 |
ESC242 |
Esophagus cancer tissue array, 12 cases 24 cores; ihc H&E, IHC anti-Cytokeratin |
US Biomax |
|
205€ |
|
Pub |
FBN404 Multiple organ normal frozen tissue array, 20 cases 40 cores US Biomax 167 |
FBN404 |
Multiple organ normal frozen tissue array, 20 cases 40 cores |
US Biomax |
|
167€ |
|
Pub |
FBN406 Multiple organ normal frozen tissue array, 20 cases 40 cores, replacing FBN404 US Biomax 167 |
FBN406 |
Multiple organ normal frozen tissue array, 20 cases 40 cores, replacing FBN404 |
US Biomax |
|
167€ |
|
Pub |
FBN407 Multiple organ normal frozen tissue array, 20 cases 40 cores, replacing FBN404 US Biomax 281 |
FBN407 |
Multiple organ normal frozen tissue array, 20 cases 40 cores, replacing FBN404 |
US Biomax |
|
281€ |
|
Pub |
FCO401 Colorectal organ carcinoma frozen tissue array, including TNM, clinical stage, 40 cases 40 cores, replaced by FCO401a US Biomax 293 |
FCO401 |
Colorectal organ carcinoma frozen tissue array, including TNM, clinical stage, 40 cases 40 cores, replaced by FCO401a |
US Biomax |
|
293€ |
|
Pub |
FDG281f Normal dog multiple organ frozen tissue array, 28 cases 28 cores US Biomax 199 |
FDG281f |
Normal dog multiple organ frozen tissue array, 28 cases 28 cores |
US Biomax |
|
199€ |
|
Pub |
FDG281m Normal male dog multiple organ frozen tissue array, 28 cases 28 cores US Biomax 199 |
FDG281m |
Normal male dog multiple organ frozen tissue array, 28 cases 28 cores |
US Biomax |
|
199€ |
|
Pub |
FMC402 Multiple organ cancer frozen tissue array, with normal tissue 40 cases 40 cores US Biomax 91 |
FMC402 |
Multiple organ cancer frozen tissue array, with normal tissue 40 cases 40 cores |
US Biomax |
|
91€ |
|
Pub |
FMC405 Multiple organ carcinoma frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 167 |
FMC405 |
Multiple organ carcinoma frozen tissue array, including TNM and clinical stage, 40 cases 40 cores |
US Biomax |
|
167€ |
|
Pub |
FMC407 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 331 |
FMC407 |
Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores |
US Biomax |
|
331€ |
|
Pub |
FMC408 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores US Biomax 167 |
FMC408 |
Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases 40 cores |
US Biomax |
|
167€ |
|
Pub |
FMC409 Multiple organ cancer frozen tissue array, 20 cases 40 cores replacing FMC401 US Biomax 281 |
FMC409 |
Multiple organ cancer frozen tissue array, 20 cases 40 cores replacing FMC401 |
US Biomax |
|
281€ |
|
Pub |
FRB281f Normal female rabbit multiple organ frozen tissue array, 28 cases 28 cores US Biomax 293 |
FRB281f |
Normal female rabbit multiple organ frozen tissue array, 28 cases 28 cores |
US Biomax |
|
293€ |
|
Pub |
FRB281m Normal male rabbit multiple organ frozen tissue array, 28 cases 28 cores US Biomax 293 |
FRB281m |
Normal male rabbit multiple organ frozen tissue array, 28 cases 28 cores |
US Biomax |
|
293€ |
|
Pub |
HER2 Her-2 IHC Bio-marker control TMA, for CAP proficiency test survey, with breast invasive ductal carcinoma, 10 cases 10 cores; ihc Anti-Actin confirmed US Biomax 114 |
HER2 |
Her-2 IHC Bio-marker control TMA, for CAP proficiency test survey, with breast invasive ductal carcinoma, 10 cases 10 cores; ihc Anti-Actin confirmed |
US Biomax |
|
114€ |
|
Pub |
IQ417 Mouse Anti-Human Fibronectin Target Antigen Fibronectin Host Isotype Mouse IgG1 Application IHC (P); Immunohistochemical staining of matrix fibronectin in normal and malignant tissues on frozen sec Imunquest 0.1ml (1mg/ml) 492 |
IQ417 |
Mouse Anti-Human Fibronectin Target Antigen Fibronectin Host Isotype Mouse IgG1 Application IHC (P); Immunohistochemical staining of matrix fibronectin in normal and malignant tissues on frozen sec |
Imunquest |
0.1ml (1mg/ml) |
492€ |
|
Pub |
IQ422 Mouse Anti-Ca19.9 Sialyl Lewis a Target Antigen Ca19.9 Sialyl Lewis a Host Isotype Mouse IgM Application Suitable for staining formalin fixed paraffin wax embedded tissue sections without protease Imunquest 0.1ml (1mg/ml) 492 |
IQ422 |
Mouse Anti-Ca19.9 Sialyl Lewis a Target Antigen Ca19.9 Sialyl Lewis a Host Isotype Mouse IgM Application Suitable for staining formalin fixed paraffin wax embedded tissue sections without protease |
Imunquest |
0.1ml (1mg/ml) |
492€ |
|
Pub |
LC2081 Multiple lung carcinoma (Non small cell lung carcinoma, NSCLC) and normal tissue form necroscopy tissue array, 70 cases 208 cores, with stage and grade information US Biomax 456 |
LC2081 |
Multiple lung carcinoma (Non small cell lung carcinoma, NSCLC) and normal tissue form necroscopy tissue array, 70 cases 208 cores, with stage and grade information |
US Biomax |
|
456€ |
|
Pub |
LYM401 Lymphoma array, together with LYM321, LYM761 and LYM771 forming the lymphoma array set, 39 cases 40 cores US Biomax 142 |
LYM401 |
Lymphoma array, together with LYM321, LYM761 and LYM771 forming the lymphoma array set, 39 cases 40 cores |
US Biomax |
|
142€ |
|
Pub |
M37091733 4 Formylimidazole (4(5) Imidazolecarboxaldehyde) CAS Number [3034 50 2] Molekula 1 G 88 |
M37091733 |
4 Formylimidazole (4(5) Imidazolecarboxaldehyde) CAS Number [3034 50 2] |
Molekula |
1 G |
88€ |
|
Pub |
MC616 High density lung, breast, brain and colon cancer array, with stage, grade and normal tissue array, 308 cases 616 cores US Biomax 753 |
MC616 |
High density lung, breast, brain and colon cancer array, with stage, grade and normal tissue array, 308 cases 616 cores |
US Biomax |
|
753€ |
|
Pub |
MC961 Multiple organ cancer tissue array for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replaced by MC964 US Biomax 231 |
MC961 |
Multiple organ cancer tissue array for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replaced by MC964 |
US Biomax |
|
231€ |
|
Pub |
MC964 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replacing MC961 US Biomax 266 |
MC964 |
Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, for testing tumor tissue specificity of therapeutic antibodies, 96 cases 96 cores, replacing MC961 |
US Biomax |
|
266€ |
|
Pub |
MCA1893 MOUSE ANTI CANINE DISTEMPER VIRUS, Product Type Monoclonal Antibody, Specificity CANINE DISTEMPER VIRUS, Target Species Viral, Host Mouse, Format Purified, Isotypes IgG2b, Applications C, E, P* AbD Serotec 0.25 mg 456 |
MCA1893 |
MOUSE ANTI CANINE DISTEMPER VIRUS, Product Type Monoclonal Antibody, Specificity CANINE DISTEMPER VIRUS, Target Species Viral, Host Mouse, Format Purified, Isotypes IgG2b, Applications C, E, P* |
AbD Serotec |
0.25 mg |
456€ |
|
Pub |
MCA4610T MOUSE ANTI HUMAN CD15, Product Type Monoclonal Antibody, Specificity CD15, Target Species Human, Host Mouse, Format Purified, Isotypes IgM, Applications C, F, P, Clone HI98 AbD Serotec 25 µg 148.05 |
MCA4610T |
MOUSE ANTI HUMAN CD15, Product Type Monoclonal Antibody, Specificity CD15, Target Species Human, Host Mouse, Format Purified, Isotypes IgM, Applications C, F, P, Clone HI98 |
AbD Serotec |
25 µg |
148.05€ |
|
Pub |
MHH-030n Anti 4 hydroxy 2 hexenal (4 HHE) monoclonal antibody JaICA 30 micro gram 678 |
MHH-030n |
Anti 4 hydroxy 2 hexenal (4 HHE) monoclonal antibody |
JaICA |
30 micro gram |
678€ |
|
Pub |
MMD-030n Anti malondialdehyde (MDA) monoclonal antibody JaICA 30 micro gram 563 |
MMD-030n |
Anti malondialdehyde (MDA) monoclonal antibody |
JaICA |
30 micro gram |
563€ |
|
Pub |
MMG-030n Anti methyglyoxal (MG) monoclonal antibody JaICA 30 micro gram 563 |
MMG-030n |
Anti methyglyoxal (MG) monoclonal antibody |
JaICA |
30 micro gram |
563€ |
|
Pub |
MNO341 Antibody cross reactivity testing tissue array, 33 cases 34 cores US Biomax 118 |
MNO341 |
Antibody cross reactivity testing tissue array, 33 cases 34 cores |
US Biomax |
|
118€ |
|
Pub |
MNT241 Multiple tumor and normal tissue array for IHC antibody and ISH probe optimization and initial screening, 12 cases 24 cores US Biomax 77 |
MNT241 |
Multiple tumor and normal tissue array for IHC antibody and ISH probe optimization and initial screening, 12 cases 24 cores |
US Biomax |
|
77€ |
|
Pub |
OV603 Ovarian serous cystadenoma tissue array, 30 cases 60 cores US Biomax 231 |
OV603 |
Ovarian serous cystadenoma tissue array, 30 cases 60 cores |
US Biomax |
|
231€ |
|
Pub |
OV806 Normal ovarian tissue array, 30 cases 60 cores US Biomax 231 |
OV806 |
Normal ovarian tissue array, 30 cases 60 cores |
US Biomax |
|
231€ |
|
Pub |
QAH-CAA-3000-SW Q-Analyzer Software for QAH-CAA-3000 Antibody Array Ray Biotech 4 modules 1030 |
QAH-CAA-3000-SW |
Q-Analyzer Software for QAH-CAA-3000 Antibody Array |
Ray Biotech |
4 modules |
1030€ |
|
Pub |
QAM-CAA-3000-SW Q-Analyzer Software for QAM-CAA-3000 Antibody Array Ray Biotech 4 modules 1030 |
QAM-CAA-3000-SW |
Q-Analyzer Software for QAM-CAA-3000 Antibody Array |
Ray Biotech |
4 modules |
1030€ |
|
Pub |
SCH-MCA2454PE MOUSE ANTI HUMAN CD19 RPE, Product Type Monoclonal Antibody, Specificity CD19, Target Species Human, Host Mouse, Format RPE, Isotypes IgG1, Applications F, Clone LE CD19 Serotech 100 TESTS 421 |
SCH-MCA2454PE |
MOUSE ANTI HUMAN CD19 RPE, Product Type Monoclonal Antibody, Specificity CD19, Target Species Human, Host Mouse, Format RPE, Isotypes IgG1, Applications F, Clone LE CD19 |
Serotech |
100 TESTS |
421€ |
|
Pub |
SCH-MCA4610T MOUSE ANTI HUMAN CD15, Product Type Monoclonal Antibody, Specificity CD15, Target Species Human, Host Mouse, Format Purified, Isotypes IgM, Applications C, F, P, Clone HI98 Serotech 25 µg 148.05 |
SCH-MCA4610T |
MOUSE ANTI HUMAN CD15, Product Type Monoclonal Antibody, Specificity CD15, Target Species Human, Host Mouse, Format Purified, Isotypes IgM, Applications C, F, P, Clone HI98 |
Serotech |
25 µg |
148.05€ |
|
Pub |
SO802 Malignant fibrohistiocytoma tissue array, 80 cases 80 cores; ihc CD68 confirmed US Biomax 267 |
SO802 |
Malignant fibrohistiocytoma tissue array, 80 cases 80 cores; ihc CD68 confirmed |
US Biomax |
|
267€ |
|
Pub |
SO808 Schwannoma (neurilemmoma or neurinoma) of central nerve tissue array, 30 cases 60 cores US Biomax 266 |
SO808 |
Schwannoma (neurilemmoma or neurinoma) of central nerve tissue array, 30 cases 60 cores |
US Biomax |
|
266€ |
|
Pub |
STAR67 MOUSE ANTI APAAP COMPLEX, Product Type Monoclonal Antibody, Specificity APAAP COMPLEX, Target Species Chemical, Host Mouse, Format Complex, Isotypes IgG1, Applications C, P, RE, Clone WR31 AbD Serotec 1 ml 361 |
STAR67 |
MOUSE ANTI APAAP COMPLEX, Product Type Monoclonal Antibody, Specificity APAAP COMPLEX, Target Species Chemical, Host Mouse, Format Complex, Isotypes IgG1, Applications C, P, RE, Clone WR31 |
AbD Serotec |
1 ml |
361€ |
|
Pub |
UTE601 Fallopian tube disease spectrum (fallopian tube cancer progression) tissue array, 30 cases 60 cores US Biomax 266 |
UTE601 |
Fallopian tube disease spectrum (fallopian tube cancer progression) tissue array, 30 cases 60 cores |
US Biomax |
|
266€ |
|
Pub |
Y050800 Anti-daf-2(Abnormal dauer formation protein 2) Antibody ABM Goods 100ug 386 |
Y050800 |
Anti-daf-2(Abnormal dauer formation protein 2) Antibody |
ABM Goods |
100ug |
386€ |
|
Pub |
Y051499 Anti- ADAM-12 (A Disintigrin And Metalloproteinase-1, Meltrin-a) Cytoplasmic domain ADAM-12 (long form) Antibody ABM Goods 100μg 811.65 |
Y051499 |
Anti- ADAM-12 (A Disintigrin And Metalloproteinase-1, Meltrin-a) Cytoplasmic domain ADAM-12 (long form) Antibody |
ABM Goods |
100μg |
811.65€ |
|
Pub |
Y051539 Anti-ADAMTS-13 (A Disintigrin And Metalloproteinase with ThromboSpondin motif-13, von Willebrand factor-cleaving protease); Carboxyterminal end long form Antibody ABM Goods 100μg 811.65 |
Y051539 |
Anti-ADAMTS-13 (A Disintigrin And Metalloproteinase with ThromboSpondin motif-13, von Willebrand factor-cleaving protease); Carboxyterminal end long form Antibody |
ABM Goods |
100μg |
811.65€ |
|
Pub |
Y051627 Anti-BMP-1 (Bone Morphogenic Protein-1, ProCollagen C-endopeptidase, PCP, mTld); Carboxyterminal end long form Antibody ABM Goods 100μg 811 |
Y051627 |
Anti-BMP-1 (Bone Morphogenic Protein-1, ProCollagen C-endopeptidase, PCP, mTld); Carboxyterminal end long form Antibody |
ABM Goods |
100μg |
811€ |
|
Pub |
Y059034 Anti-Human Dopamine Beta-Hydroxylase Antibody ABM Goods 30ug 254 |
Y059034 |
Anti-Human Dopamine Beta-Hydroxylase Antibody |
ABM Goods |
30ug |
254€ |
|
Pub |
Y061027 Anti-Actin (20-33) produced in rabbit Antibody ABM Goods 100ul 857.85 |
Y061027 |
Anti-Actin (20-33) produced in rabbit Antibody |
ABM Goods |
100ul |
857.85€ |
|
Pub |
Y090078 Anti-actin binding protein 34 (ABP34) Monoclonal Antibody ABM Goods 100ul 265.65 |
Y090078 |
Anti-actin binding protein 34 (ABP34) Monoclonal Antibody |
ABM Goods |
100ul |
265.65€ |
|
Pub |
Y090087 Anti-actin binding protein 34 (ABP34) Antibody ABM Goods 100ul 265.65 |
Y090087 |
Anti-actin binding protein 34 (ABP34) Antibody |
ABM Goods |
100ul |
265.65€ |
|
Pub |
PMT030 Permanent Mounting Media (Aqueous) Scy tek 30 ml 100 |
PMT030 |
Permanent Mounting Media (Aqueous) |
Scy tek |
30 ml |
100€ |
|
Pub |
128-10165-3 Rabbit Anti-SARS-Associated Coronavirus Nucleocapsid Protein Ray Biotech 300 2320 |
128-10165-3 |
Rabbit Anti-SARS-Associated Coronavirus Nucleocapsid Protein |
Ray Biotech |
300 |
2320€ |
|
Pub |
128-10168-3 Rabbit Anti-SARS-Associated Coronavirus Spike Protein Ray Biotech 300 2320 |
128-10168-3 |
Rabbit Anti-SARS-Associated Coronavirus Spike Protein |
Ray Biotech |
300 |
2320€ |
|
Pub |
21055 Akt (Ab 308) Antibody Host Species Rabbit polyclonal SignalWay Antibody S.A.B 50 ug 143 |
21055 |
Akt (Ab 308) Antibody Host Species Rabbit polyclonal |
SignalWay Antibody S.A.B |
50 ug |
143€ |
|
Pub |
21206 HSF1 (Ab 307) Antibody Host Species Rabbit polyclonal SignalWay Antibody S.A.B 50 ug 143 |
21206 |
HSF1 (Ab 307) Antibody Host Species Rabbit polyclonal |
SignalWay Antibody S.A.B |
50 ug |
143€ |
|
Pub |
21255 HSF1 (Ab 303) Antibody Host Species Rabbit polyclonal SignalWay Antibody S.A.B 50 ug 143 |
21255 |
HSF1 (Ab 303) Antibody Host Species Rabbit polyclonal |
SignalWay Antibody S.A.B |
50 ug |
143€ |
|
Pub |
21292 Synaptotagmin (Ab 309) Antibody Host Species Rabbit polyclonal SignalWay Antibody S.A.B 50 ug 143 |
21292 |
Synaptotagmin (Ab 309) Antibody Host Species Rabbit polyclonal |
SignalWay Antibody S.A.B |
50 ug |
143€ |
|
Pub |
22164 YKL-39 antibody Source Rabbit Polyconal Ab Species Human Application WB IHC SignalWay Antibody S.A.B 100ul 329 |
22164 |
YKL-39 antibody Source Rabbit Polyconal Ab Species Human Application WB IHC |
SignalWay Antibody S.A.B |
100ul |
329€ |
|
Pub |
22171 succinate-CoA ligase, GDP-forming beta subunit precursor antibody Source Rabbit Polyconal Ab Species Human Application WB IF SignalWay Antibody S.A.B 100ul 329 |
22171 |
succinate-CoA ligase, GDP-forming beta subunit precursor antibody Source Rabbit Polyconal Ab Species Human Application WB IF |
SignalWay Antibody S.A.B |
100ul |
329€ |
|
Pub |
22179 Peroxin 26 antibody Source Rabbit Polyconal Ab Species Human Application WB IHC IF SignalWay Antibody S.A.B 100ul 329 |
22179 |
Peroxin 26 antibody Source Rabbit Polyconal Ab Species Human Application WB IHC IF |
SignalWay Antibody S.A.B |
100ul |
329€ |
|
Pub |
22190 Glutathione peroxidase 7 antibody Source Rabbit Polyconal Ab Species Human Application WB IHC SignalWay Antibody S.A.B 100ul 329 |
22190 |
Glutathione peroxidase 7 antibody Source Rabbit Polyconal Ab Species Human Application WB IHC |
SignalWay Antibody S.A.B |
100ul |
329€ |
|
Pub |
22524 actin-like 8 antibody Source Rabbit Polyconal Ab Species Human Application WB IHC IF SignalWay Antibody S.A.B 100ul 329 |
22524 |
actin-like 8 antibody Source Rabbit Polyconal Ab Species Human Application WB IHC IF |
SignalWay Antibody S.A.B |
100ul |
329€ |
|
Pub |
22593 alpha Actinin 4 antibody Source Rabbit Polyconal Ab Species human Application WB IHC IF SignalWay Antibody S.A.B 100ul 329 |
22593 |
alpha Actinin 4 antibody Source Rabbit Polyconal Ab Species human Application WB IHC IF |
SignalWay Antibody S.A.B |
100ul |
329€ |
|
Pub |
22776 formin-like 1 antibody Source Rabbit Polyconal Ab Species Human Application WB SignalWay Antibody S.A.B 100ul 329 |
22776 |
formin-like 1 antibody Source Rabbit Polyconal Ab Species Human Application WB |
SignalWay Antibody S.A.B |
100ul |
329€ |
|
Pub |
22910 I-309 antibody Source Rabbit Polyconal Ab Species Human Application WB SignalWay Antibody S.A.B 100ul 329 |
22910 |
I-309 antibody Source Rabbit Polyconal Ab Species Human Application WB |
SignalWay Antibody S.A.B |
100ul |
329€ |
|
Pub |
22954 Actin antibody Source Rabbit Polyconal Ab Species Human Application WB IHC SignalWay Antibody S.A.B 100ul 329 |
22954 |
Actin antibody Source Rabbit Polyconal Ab Species Human Application WB IHC |
SignalWay Antibody S.A.B |
100ul |
329€ |
|
Pub |
22956 Alpha Smooth Muscle Actin antibody Source Rabbit Polyconal Ab Species Human Application WB IHC SignalWay Antibody S.A.B 100ul 329 |
22956 |
Alpha Smooth Muscle Actin antibody Source Rabbit Polyconal Ab Species Human Application WB IHC |
SignalWay Antibody S.A.B |
100ul |
329€ |
|
Pub |
22957 Beta Actin antibody Source Rabbit Polyconal Ab Species Human Application WB IHC IF SignalWay Antibody S.A.B 100ul 329 |
22957 |
Beta Actin antibody Source Rabbit Polyconal Ab Species Human Application WB IHC IF |
SignalWay Antibody S.A.B |
100ul |
329€ |
|
Pub |
22958 alpha sarcomeric Actin antibody Source Rabbit Polyconal Ab Species Human Application WB IHC SignalWay Antibody S.A.B 100ul 329 |
22958 |
alpha sarcomeric Actin antibody Source Rabbit Polyconal Ab Species Human Application WB IHC |
SignalWay Antibody S.A.B |
100ul |
329€ |
|
Pub |
22959 Actin antibody Source Rabbit Polyconal Ab Species Human Application WB IHC SignalWay Antibody S.A.B 100ul 329 |
22959 |
Actin antibody Source Rabbit Polyconal Ab Species Human Application WB IHC |
SignalWay Antibody S.A.B |
100ul |
329€ |
|
Pub |
23012 Histone H3.3B antibody Source Rabbit Polyconal Ab Species Human Application WB IHC IF SignalWay Antibody S.A.B 100ul 329 |
23012 |
Histone H3.3B antibody Source Rabbit Polyconal Ab Species Human Application WB IHC IF |
SignalWay Antibody S.A.B |
100ul |
329€ |
|
Pub |
23069 RPA 32 kDa subunit antibody Source Rabbit Polyconal Ab Species Human Application WB IHC IF SignalWay Antibody S.A.B 100ul 329 |
23069 |
RPA 32 kDa subunit antibody Source Rabbit Polyconal Ab Species Human Application WB IHC IF |
SignalWay Antibody S.A.B |
100ul |
329€ |
|
Pub |
24016 Primary antibody Caspase-10 Antibody, Source Rabbit, Species Reactivity Antibody only recognizes FLICE2 form of caspase-10. SignalWay Antibody S.A.B 100ug 364 |
24016 |
Primary antibody Caspase-10 Antibody, Source Rabbit, Species Reactivity Antibody only recognizes FLICE2 form of caspase-10. |
SignalWay Antibody S.A.B |
100ug |
364€ |
|
Pub |
24027 Primary antibody FLIP Antibody, Source Rabbit, Species Reactivity FLIP has short form (FLIPS) and long form (FLIPL) and antibody recognizes the FLIPL only. SignalWay Antibody S.A.B 100ug 364 |
24027 |
Primary antibody FLIP Antibody, Source Rabbit, Species Reactivity FLIP has short form (FLIPS) and long form (FLIPL) and antibody recognizes the FLIPL only. |
SignalWay Antibody S.A.B |
100ug |
364€ |
|
Pub |
30118 Cell Culture Chamber slide, Black,8 wells, PS frame, glass slide, PP holder, 0.2~0.6ml,Sterile, 6 12 case box size(mm):300x123x60 SPL 6/12 Packing /sleeve/box x 2 128 |
30118 |
Cell Culture Chamber slide, Black,8 wells, PS frame, glass slide, PP holder, 0.2~0.6ml,Sterile, 6 12 case box size(mm):300x123x60 |
SPL |
6/12 Packing /sleeve/box x 2 |
128€ |
|
Pub |
304-13041 Anti RAGE (Receptor for AGE) Human, Polyclonal Antibody, Rabbit RAGE is the receptor of AGEs, advanced glycation end products with 35,000 molecular weight and was cloned from bovine lung in 1992 ( Da B-Bridge 100 UG 854.7 |
304-13041 |
Anti RAGE (Receptor for AGE) Human, Polyclonal Antibody, Rabbit RAGE is the receptor of AGEs, advanced glycation end products with 35,000 molecular weight and was cloned from bovine lung in 1992 ( Da |
B-Bridge |
100 UG |
854.7€ |
|
Pub |
305-34819 Anti trimethyl Histone H3 (3Me-Lys4) monoclonal Antibody Antibodies B-Bridge 100 ul 534 |
305-34819 |
Anti trimethyl Histone H3 (3Me-Lys4) monoclonal Antibody Antibodies |
B-Bridge |
100 ul |
534€ |
|
Pub |
305-34819 Anti trimethyl Histone H3 (3Me Lys4) monoclonal Antibody B-Bridge 100 ul 602.868 |
305-34819 |
Anti trimethyl Histone H3 (3Me Lys4) monoclonal Antibody |
B-Bridge |
100 ul |
602.868€ |
|
Pub |
305-34819 Anti trimethyl Histone H3 (3Me Lys4) monoclonal Antibody Binds to lysine 4 trimethylated Histone H3 with or without Lys9 aceylation Subtype IgG1 k B-Bridge 100 ul 445.2 |
305-34819 |
Anti trimethyl Histone H3 (3Me Lys4) monoclonal Antibody Binds to lysine 4 trimethylated Histone H3 with or without Lys9 aceylation Subtype IgG1 k |
B-Bridge |
100 ul |
445.2€ |
|
Pub |
309-34839 Anti-trimethyl Histone H3 (3Me-Lys9) monoclonal antibody Antibodies B-Bridge 100 ul 534 |
309-34839 |
Anti-trimethyl Histone H3 (3Me-Lys9) monoclonal antibody Antibodies |
B-Bridge |
100 ul |
534€ |
|
Pub |
309-34839 Anti trimethyl Histone H3 (3Me Lys9) monoclonal antibody B-Bridge 100 ul 602.868 |
309-34839 |
Anti trimethyl Histone H3 (3Me Lys9) monoclonal antibody |
B-Bridge |
100 ul |
602.868€ |
|
Pub |
309-34839 Anti trimethyl Histone H3 (3Me Lys9) monoclonal antibody Binds to Histone H3 trimethylated at lysine 9. Blocked by Ser10 phosphorylation. Subtype IgG1 k B-Bridge 100 ul 445.2 |
309-34839 |
Anti trimethyl Histone H3 (3Me Lys9) monoclonal antibody Binds to Histone H3 trimethylated at lysine 9. Blocked by Ser10 phosphorylation. Subtype IgG1 k |
B-Bridge |
100 ul |
445.2€ |
|
Pub |
4828-30-AC TACS.XL Antibody Module Trevigen 30 Samples 157 |
4828-30-AC |
TACS.XL Antibody Module |
Trevigen |
30 Samples |
157€ |
|
Pub |
A167990 3-O-Acetyl 5,14-Androstadiene-3β,17β-diol C21H30O3 CAS: 61252-30-0 TRC 25 mg 219 |
A167990 |
3-O-Acetyl 5,14-Androstadiene-3β,17β-diol C21H30O3 CAS: 61252-30-0 |
TRC |
25 mg |
219€ |
|
Pub |
A176100 N-γ-Acetyl-N-2-formyl-5-methoxykynurenamine C13H16N2O4 CAS: 52450-38-1 TRC 10 mg 193 |
A176100 |
N-γ-Acetyl-N-2-formyl-5-methoxykynurenamine C13H16N2O4 CAS: 52450-38-1 |
TRC |
10 mg |
193€ |
|
Pub |
A609660 6-Amino-5-formylamino-3H-pyrimidine-4-one C5H6N4O2 CAS: 64194-58-7 TRC 100 mg 245 |
A609660 |
6-Amino-5-formylamino-3H-pyrimidine-4-one C5H6N4O2 CAS: 64194-58-7 |
TRC |
100 mg |
245€ |
|
Pub |
A798200 (3R,4S,5R,6S)-1-Aza-4-hydroxy-5-formyl-6-isopropyl-3-methyl-7-oxabicycl[3.3.0]octan-2-one C11H17NO4 CAS: 145452-03-5 TRC 1 mg 180 |
A798200 |
(3R,4S,5R,6S)-1-Aza-4-hydroxy-5-formyl-6-isopropyl-3-methyl-7-oxabicycl[3.3.0]octan-2-one C11H17NO4 CAS: 145452-03-5 |
TRC |
1 mg |
180€ |
|
Pub |
AA0043 Angiogenesis (Human) Antibody Array (G) includes 20 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 731 |
AA0043 |
Angiogenesis (Human) Antibody Array (G) includes 20 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
731€ |
|
Pub |
AA0044 Angiogenesis (Human) Antibody Array (G) includes 23 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 731 |
AA0044 |
Angiogenesis (Human) Antibody Array (G) includes 23 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
731€ |
|
Pub |
AA0045 Angiogenesis (Mouse) Antibody Array (G) includes 24 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 731 |
AA0045 |
Angiogenesis (Mouse) Antibody Array (G) includes 24 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
731€ |
|
Pub |
AA0046 Apoptosis (Human) Antibody Array (G) includes 43 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 731 |
AA0046 |
Apoptosis (Human) Antibody Array (G) includes 43 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
731€ |
|
Pub |
AA0047 Cytokine (Human) Antibody Array (G) includes 42 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 731 |
AA0047 |
Cytokine (Human) Antibody Array (G) includes 42 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
731€ |
|
Pub |
AA0048 Cytokine (Human) Antibody Array (G) includes 80 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 888 |
AA0048 |
Cytokine (Human) Antibody Array (G) includes 80 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
888€ |
|
Pub |
AA0049 Cytokine (Human) Antibody Array (G) includes 60 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 888 |
AA0049 |
Cytokine (Human) Antibody Array (G) includes 60 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
888€ |
|
Pub |
AA0050 Cytokine (Human) Antibody Array (G) includes 60 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 888 |
AA0050 |
Cytokine (Human) Antibody Array (G) includes 60 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
888€ |
|
Pub |
AA0051 Cytokine (Human) Antibody Array (G) includes 54 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 888 |
AA0051 |
Cytokine (Human) Antibody Array (G) includes 54 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
888€ |
|
Pub |
AA0052 Cytokine (Human) Antibody Array (G) includes 51 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 888 |
AA0052 |
Cytokine (Human) Antibody Array (G) includes 51 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
888€ |
|
Pub |
AA0053 Cytokine (Human) Antibody Array (G) includes 49 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 888 |
AA0053 |
Cytokine (Human) Antibody Array (G) includes 49 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
888€ |
|
Pub |
AA0055 Cytokine (Mouse) Antibody Array (G) includes 62 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 888 |
AA0055 |
Cytokine (Mouse) Antibody Array (G) includes 62 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
888€ |
|
Pub |
AA0057 Cytokine (Mouse) Antibody Array (G) includes 48 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 731 |
AA0057 |
Cytokine (Mouse) Antibody Array (G) includes 48 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
731€ |
|
Pub |
AA0058 Cytokine (Mouse) Antibody Array (G) includes 97 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 1323 |
AA0058 |
Cytokine (Mouse) Antibody Array (G) includes 97 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
1323€ |
|
Pub |
AA0059 Cytokine (Rat) Antibody Array (G) includes 19 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 731 |
AA0059 |
Cytokine (Rat) Antibody Array (G) includes 19 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
731€ |
|
Pub |
AA0061 Inflammation (Human) Antibody Array (G) includes 40 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 731 |
AA0061 |
Inflammation (Human) Antibody Array (G) includes 40 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
731€ |
|
Pub |
AA0062 Inflammation (Mouse) Antibody Array (G) includes 40 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 731 |
AA0062 |
Inflammation (Mouse) Antibody Array (G) includes 40 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
731€ |
|
Pub |
AA0063 Obesity (Human) Antibody Array (G) includes 62 highly specific and well-characterized antibodies on glass slide. Abnova 4 Arrays/Slide 888 |
AA0063 |
Obesity (Human) Antibody Array (G) includes 62 highly specific and well-characterized antibodies on glass slide. |
Abnova |
4 Arrays/Slide |
888€ |
|
Pub |
AA0071 Chemokine (Human) Antibody Array includes 38 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 731 |
AA0071 |
Chemokine (Human) Antibody Array includes 38 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
731€ |
|
Pub |
AA0074 Cytokine (Human) Antibody Array includes 36 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 731 |
AA0074 |
Cytokine (Human) Antibody Array includes 36 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
731€ |
|
Pub |
AA0082 Cytokine (Mouse) Antibody Array includes 32 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 731 |
AA0082 |
Cytokine (Mouse) Antibody Array includes 32 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
731€ |
|
Pub |
AA0084 Cytokine (Mouse) Antibody Array includes 34 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 731 |
AA0084 |
Cytokine (Mouse) Antibody Array includes 34 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
731€ |
|
Pub |
AA0088 Cytokine (Rat) Antibody Array includes 34 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 731 |
AA0088 |
Cytokine (Rat) Antibody Array includes 34 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
731€ |
|
Pub |
AA0096 Th1 Th2 Th17 (Human) Antibody Array includes 34 highly specific and well-characterized antibodies on membrane. Abnova 4 Membranes/Box 731 |
AA0096 |
Th1 Th2 Th17 (Human) Antibody Array includes 34 highly specific and well-characterized antibodies on membrane. |
Abnova |
4 Membranes/Box |
731€ |
|
Pub |
AA0097 Obesity (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 10 human adipokines in 8-10 samples. Abnova 16 Arrays/Slide 754 |
AA0097 |
Obesity (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 10 human adipokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
754€ |
|
Pub |
AA0098 Obesity (Human) Quantitative Antibody Array 2 is a multiplex antibody array for the quantitative measurement of 4 human adipokines in 8-10 samples. Abnova 16 Arrays/Slide 429 |
AA0098 |
Obesity (Human) Quantitative Antibody Array 2 is a multiplex antibody array for the quantitative measurement of 4 human adipokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
429€ |
|
Pub |
AA0099 Angiogenesis (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 10 human angiogenic factors in 8-10 samples. Abnova 16 Arrays/Slide 754 |
AA0099 |
Angiogenesis (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 10 human angiogenic factors in 8-10 samples. |
Abnova |
16 Arrays/Slide |
754€ |
|
Pub |
AA0102 Chemokine (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 40 human chemokines in 8-10 samples. Abnova 16 Arrays/Slide 1764 |
AA0102 |
Chemokine (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 40 human chemokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
1764€ |
|
Pub |
AA0103 Cytokine (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 20 human cytokines in 8-10 samples. Abnova 16 Arrays/Slide 1068 |
AA0103 |
Cytokine (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 20 human cytokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
1068€ |
|
Pub |
AA0104 Cytokine (Human) Quantitative Antibody Array 2 is a multiplex antibody array for the quantitative measurement of 20 human cytokines in 8-10 samples. Abnova 16 Arrays/Slide 1068 |
AA0104 |
Cytokine (Human) Quantitative Antibody Array 2 is a multiplex antibody array for the quantitative measurement of 20 human cytokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
1068€ |
|
Pub |
AA0105 Cytokine (Human) Quantitative Antibody Array 4 is a multiplex antibody array for the quantitative measurement of 40 human cytokines in 8-10 samples. Abnova 16 Arrays/Slide 1764 |
AA0105 |
Cytokine (Human) Quantitative Antibody Array 4 is a multiplex antibody array for the quantitative measurement of 40 human cytokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
1764€ |
|
Pub |
AA0106 Cytokine (Human) Quantitative Antibody Array 5 is a multiplex antibody array for the quantitative measurement of 40 human cytokines in 8-10 samples. Abnova 16 Arrays/Slide 1764 |
AA0106 |
Cytokine (Human) Quantitative Antibody Array 5 is a multiplex antibody array for the quantitative measurement of 40 human cytokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
1764€ |
|
Pub |
AA0107 Cytokine (Human) Quantitative Antibody Array 6 is a multiplex antibody array for the quantitative measurement of 40 human cytokines in 8-10 samples. Abnova 16 Arrays/Slide 1764 |
AA0107 |
Cytokine (Human) Quantitative Antibody Array 6 is a multiplex antibody array for the quantitative measurement of 40 human cytokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
1764€ |
|
Pub |
AA0108 Growth Factor (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 40 human growth factors in 8-10 samples. Abnova 16 Arrays/Slide 1764 |
AA0108 |
Growth Factor (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 40 human growth factors in 8-10 samples. |
Abnova |
16 Arrays/Slide |
1764€ |
|
Pub |
AA0109 IGF-1R Signaling (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 10 human cytokines in 8-10 samples. Abnova 16 Arrays/Slide 754 |
AA0109 |
IGF-1R Signaling (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 10 human cytokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
754€ |
|
Pub |
AA0110 Inflammation (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 10 human cytokines in 8-10 samples. Abnova 16 Arrays/Slide 754 |
AA0110 |
Inflammation (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 10 human cytokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
754€ |
|
Pub |
AA0111 Inflammation (Human) Quantitative Antibody Array 2 is a multiplex antibody array for the quantitative measurement of 10 human cytokines in 8-10 samples. Abnova 16 Arrays/Slide 754 |
AA0111 |
Inflammation (Human) Quantitative Antibody Array 2 is a multiplex antibody array for the quantitative measurement of 10 human cytokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
754€ |
|
Pub |
AA0112 Inflammation (Human) Quantitative Antibody Array 3 is a multiplex antibody array for the quantitative measurement of 40 human cytokines in 8-10 samples. Abnova 16 Arrays/Slide 1764 |
AA0112 |
Inflammation (Human) Quantitative Antibody Array 3 is a multiplex antibody array for the quantitative measurement of 40 human cytokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
1764€ |
|
Pub |
AA0113 Ig Isotype (Human) Quantitative Antibody Array is a multiplex antibody array for the quantitative measurement of 8 human immunoglubin sub-types in 8-10 samples. Abnova 16 Arrays/Slide 638 |
AA0113 |
Ig Isotype (Human) Quantitative Antibody Array is a multiplex antibody array for the quantitative measurement of 8 human immunoglubin sub-types in 8-10 samples. |
Abnova |
16 Arrays/Slide |
638€ |
|
Pub |
AA0114 MMP (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 10 human MMPs in 8-10 samples. Abnova 16 Arrays/Slide 754 |
AA0114 |
MMP (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 10 human MMPs in 8-10 samples. |
Abnova |
16 Arrays/Slide |
754€ |
|
Pub |
AA0115 Receptor (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 40 human cytokines in 8-10 samples. Abnova 16 Arrays/Slide 1764 |
AA0115 |
Receptor (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 40 human cytokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
1764€ |
|
Pub |
AA0116 Th1 Th2 (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 10 human cytokines in 8-10 samples. Abnova 16 Arrays/Slide 754 |
AA0116 |
Th1 Th2 (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 10 human cytokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
754€ |
|
Pub |
AA0117 Th17 (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 20 human Th1, Th2, and Th17 cytokines in 8-10 samples. Abnova 16 Arrays/Slide 1068 |
AA0117 |
Th17 (Human) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 20 human Th1, Th2, and Th17 cytokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
1068€ |
|
Pub |
AA0118 Chemokine (Mouse) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 25 mouse chemokines in 8-10 samples. Abnova 16 Arrays/Slide 1416 |
AA0118 |
Chemokine (Mouse) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 25 mouse chemokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
1416€ |
|
Pub |
AA0119 Cytokine (Mouse) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 20 mouse cytokines in 8-10 samples. Abnova 16 Arrays/Slide 1068 |
AA0119 |
Cytokine (Mouse) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 20 mouse cytokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
1068€ |
|
Pub |
AA0120 Cytokine (Mouse) Quantitative Antibody Array 2 is a multiplex antibody array for the quantitative measurement of 20 mouse cytokines in 8-10 samples. Abnova 16 Arrays/Slide 1068 |
AA0120 |
Cytokine (Mouse) Quantitative Antibody Array 2 is a multiplex antibody array for the quantitative measurement of 20 mouse cytokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
1068€ |
|
Pub |
AA0121 Cytokine (Mouse) Quantitative Antibody Array 3 is a multiplex antibody array for the quantitative measurement of 20 mouse cytokines in 8-10 samples. Abnova 16 Arrays/Slide 1068 |
AA0121 |
Cytokine (Mouse) Quantitative Antibody Array 3 is a multiplex antibody array for the quantitative measurement of 20 mouse cytokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
1068€ |
|
Pub |
AA0122 Cytokine (Mouse) Quantitative Antibody Array 4 is a multiplex antibody array for the quantitative measurement of 40 mouse cytokines in 8-10 samples. Abnova 16 Arrays/Slide 1764 |
AA0122 |
Cytokine (Mouse) Quantitative Antibody Array 4 is a multiplex antibody array for the quantitative measurement of 40 mouse cytokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
1764€ |
|
Pub |
AA0123 Cytokine (Mouse) Quantitative Antibody Array 5 is a multiplex antibody array for the quantitative measurement of 40 mouse cytokines in 8-10 samples. Abnova 16 Arrays/Slide 1764 |
AA0123 |
Cytokine (Mouse) Quantitative Antibody Array 5 is a multiplex antibody array for the quantitative measurement of 40 mouse cytokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
1764€ |
|
Pub |
AA0124 Cytokine (Mouse) Quantitative Antibody Array 6 is a multiplex antibody array for the quantitative measurement of 40 mouse cytokines in 8-10 samples. Abnova 16 Arrays/Slide 1764 |
AA0124 |
Cytokine (Mouse) Quantitative Antibody Array 6 is a multiplex antibody array for the quantitative measurement of 40 mouse cytokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
1764€ |
|
Pub |
AA0125 Inflammation (Mouse) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 40 mouse cytokines in 8-10 samples. Abnova 16 Arrays/Slide 1764 |
AA0125 |
Inflammation (Mouse) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 40 mouse cytokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
1764€ |
|
Pub |
AA0126 IL (Mouse) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 20 mouse cytokines in 8-10 samples. Abnova 16 Arrays/Slide 1068 |
AA0126 |
IL (Mouse) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 20 mouse cytokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
1068€ |
|
Pub |
AA0127 IL (Mouse) Quantitative Antibody Array 2 is a multiplex antibody array for the quantitative measurement of 10 mouse cytokines in 8-10 samples. Abnova 16 Arrays/Slide 754 |
AA0127 |
IL (Mouse) Quantitative Antibody Array 2 is a multiplex antibody array for the quantitative measurement of 10 mouse cytokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
754€ |
|
Pub |
AA0128 Th17 (Mouse) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 20 mouse Th1, Th2, and Th17 cytokines in 8-10 samples. Abnova 16 Arrays/Slide 1068 |
AA0128 |
Th17 (Mouse) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 20 mouse Th1, Th2, and Th17 cytokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
1068€ |
|
Pub |
AA0129 Cytokine (Pig) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 10 pig cytokines in 8-10 samples. Abnova 16 Arrays/Slide 754 |
AA0129 |
Cytokine (Pig) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 10 pig cytokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
754€ |
|
Pub |
AA0130 Cytokine (Rat) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 10 rat cytokines in 8-10 samples. Abnova 16 Arrays/Slide 754 |
AA0130 |
Cytokine (Rat) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 10 rat cytokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
754€ |
|
Pub |
AA0131 Cytokine (Rat) Quantitative Antibody Array 2 is a multiplex antibody array for the quantitative measurement of 10 rat cytokines in 8-10 samples. Abnova 16 Arrays/Slide 754 |
AA0131 |
Cytokine (Rat) Quantitative Antibody Array 2 is a multiplex antibody array for the quantitative measurement of 10 rat cytokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
754€ |
|
Pub |
AA0132 Cytokine (Rat) Quantitative Antibody Array 3 is a multiplex antibody array for the quantitative measurement of 27 rat cytokines in 8-10 samples. Abnova 16 Arrays/Slide 1416 |
AA0132 |
Cytokine (Rat) Quantitative Antibody Array 3 is a multiplex antibody array for the quantitative measurement of 27 rat cytokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
1416€ |
|
Pub |
AA0133 Inflammation (Rat) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 10 rat cytokines in 8-10 samples. Abnova 16 Arrays/Slide 754 |
AA0133 |
Inflammation (Rat) Quantitative Antibody Array 1 is a multiplex antibody array for the quantitative measurement of 10 rat cytokines in 8-10 samples. |
Abnova |
16 Arrays/Slide |
754€ |
|
Pub |
AAM-ISO-G1-4 Rapid Mouse Ig Isotyping Array 1 (4) Antibody Arrays Isotyping Arrays Ray Biotech 32-50 Sample Kit 625 |
AAM-ISO-G1-4 |
Rapid Mouse Ig Isotyping Array 1 (4) Antibody Arrays Isotyping Arrays |
Ray Biotech |
32-50 Sample Kit |
625€ |
|
Pub |
AAR-BLG-1-4 Rat L-90 Array, Glass Slide (2) Antibody Arrays High-Density Screening Arrays Ray Biotech 4 Sample Kit 760 |
AAR-BLG-1-4 |
Rat L-90 Array, Glass Slide (2) Antibody Arrays High-Density Screening Arrays |
Ray Biotech |
4 Sample Kit |
760€ |
|
Pub |
AAR-BLG-1-8 Rat L-90 Array, Glass Slide (4) Antibody Arrays High-Density Screening Arrays Ray Biotech 8 Sample Kit 1380 |
AAR-BLG-1-8 |
Rat L-90 Array, Glass Slide (4) Antibody Arrays High-Density Screening Arrays |
Ray Biotech |
8 Sample Kit |
1380€ |
|
Pub |
AC451 Multiple organ condyloma acuminatum tissue array, 45 cases 45 cores US Biomax 331 |
AC451 |
Multiple organ condyloma acuminatum tissue array, 45 cases 45 cores |
US Biomax |
|
331€ |
|
Pub |
AMS541 Mouse(FBV strain) normal tissue array, cover 22 organs anatomic sites, 3 cases 54 cores US Biomax 225 |
AMS541 |
Mouse(FBV strain) normal tissue array, cover 22 organs anatomic sites, 3 cases 54 cores |
US Biomax |
|
225€ |
|
Pub |
AMS542 Mouse(KM strain) normal tissue array, cover 22 organs anatomic sites, 3 cases 54 cores US Biomax 225 |
AMS542 |
Mouse(KM strain) normal tissue array, cover 22 organs anatomic sites, 3 cases 54 cores |
US Biomax |
|
225€ |
|
Pub |
AMS544 Mouse normal tissue array, covering 22 organ anatomic sites, 3 cases 54 cores US Biomax 225 |
AMS544 |
Mouse normal tissue array, covering 22 organ anatomic sites, 3 cases 54 cores |
US Biomax |
|
225€ |
|
Pub |
AP21055 Rabbit anti Akt (Ab-308) AngoiPro 100.00 ul 290 |
AP21055 |
Rabbit anti Akt (Ab-308) |
AngoiPro |
100.00 ul |
290€ |
|
Pub |
AP21206 Rabbit anti HSF1 (Ab-307) AngoiPro 100.00 ul 290 |
AP21206 |
Rabbit anti HSF1 (Ab-307) |
AngoiPro |
100.00 ul |
290€ |
|
Pub |
AP21255 Rabbit anti HSF1 (Ab-303) AngoiPro 100.00 ul 290 |
AP21255 |
Rabbit anti HSF1 (Ab-303) |
AngoiPro |
100.00 ul |
290€ |
|
Pub |
ART661 Rat(Wistar strain) normal tissue array, covering all major organs, non overlapping with ART662, 22 cases 66 cores US Biomax 225 |
ART661 |
Rat(Wistar strain) normal tissue array, covering all major organs, non overlapping with ART662, 22 cases 66 cores |
US Biomax |
|
225€ |
|
Pub |
B279842 Benzyl (2S,3S,5S)-2-Hexyl-3-benzyloxy-5-[[(S)-2-(formylamino)-4-(methyl-d3)-pe
ntanoyl]oxy]hexadecanoate C43H64D3NO6 CAS: 1356931-00-4 TRC 1 mg 310 |
B279842 |
Benzyl (2S,3S,5S)-2-Hexyl-3-benzyloxy-5-[[(S)-2-(formylamino)-4-(methyl-d3)-pe
ntanoyl]oxy]hexadecanoate C43H64D3NO6 CAS: 1356931-00-4 |
TRC |
1 mg |
310€ |
|
Pub |
BC000119 Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores US Biomax 456 |
BC000119 |
Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores |
US Biomax |
|
456€ |
|
Pub |
BC000120 Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores US Biomax 456 |
BC000120 |
Multi organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases 200 cores |
US Biomax |
|
456€ |
|
Pub |
BC00014 Multiple organ diseased tissue array, 63 cases 63 cores, replaced by MC631 US Biomax 160 |
BC00014 |
Multiple organ diseased tissue array, 63 cases 63 cores, replaced by MC631 |
US Biomax |
|
160€ |
|
Pub |
BC00019 Multiple organ squamous cell carcinoma tissue array, 63 cases 63 cores US Biomax 231 |
BC00019 |
Multiple organ squamous cell carcinoma tissue array, 63 cases 63 cores |
US Biomax |
|
231€ |
|
Pub |
BC00111 Multiple organ normal and diseased tissue array (replaced by MCN601), 54 cases 60 cores US Biomax 231 |
BC00111 |
Multiple organ normal and diseased tissue array (replaced by MCN601), 54 cases 60 cores |
US Biomax |
|
231€ |
|
Pub |
BC001111 Multiple organ normal and diseased tissue array, 58 cases 60 cores, replaced by MCN601 US Biomax 231 |
BC001111 |
Multiple organ normal and diseased tissue array, 58 cases 60 cores, replaced by MCN601 |
US Biomax |
|
231€ |
|
Pub |
BC00112 Multiple organ paired normal and cancer (8 types) tissue array, 48 cases 48 cores US Biomax 160 |
BC00112 |
Multiple organ paired normal and cancer (8 types) tissue array, 48 cases 48 cores |
US Biomax |
|
160€ |
|
Pub |
BC001130 Pancreatic carcinoma and multi organ adjacent tissue array, including TNM, clinical stage and pathology grade, 81 cases 121 cores US Biomax 278 |
BC001130 |
Pancreatic carcinoma and multi organ adjacent tissue array, including TNM, clinical stage and pathology grade, 81 cases 121 cores |
US Biomax |
|
278€ |
|
Pub |
BC001134 Multiple organs tumor and normal tissue array, including TNM, clinical stage and pathology grade, 150 cases 150 cores US Biomax 397 |
BC001134 |
Multiple organs tumor and normal tissue array, including TNM, clinical stage and pathology grade, 150 cases 150 cores |
US Biomax |
|
397€ |
|
Pub |
BC00115 Multiple organ normal and diseased tissue array, 44 cases 64 cores, replaced by MC802 US Biomax 231 |
BC00115 |
Multiple organ normal and diseased tissue array, 44 cases 64 cores, replaced by MC802 |
US Biomax |
|
231€ |
|
Pub |
BC19012 Prostate carcinoma (multi tissue combined panel) tissue array, 33 cases 63 cores, replaced by PR808 US Biomax 231 |
BC19012 |
Prostate carcinoma (multi tissue combined panel) tissue array, 33 cases 63 cores, replaced by PR808 |
US Biomax |
|
231€ |
|
Pub |
BC19013 Prostate carcinoma (multi tissue combined panel) tissue array, 33 cases 63 cores US Biomax 231 |
BC19013 |
Prostate carcinoma (multi tissue combined panel) tissue array, 33 cases 63 cores |
US Biomax |
|
231€ |
|
Pub |
BC19014 Prostate carcinoma tissue array, 31 cases 63 cores US Biomax 231 |
BC19014 |
Prostate carcinoma tissue array, 31 cases 63 cores |
US Biomax |
|
231€ |
|
Pub |
BC19017 Prostate carcinoma tissue array, 33 cases 63 cores, replaced by PR809 US Biomax 160 |
BC19017 |
Prostate carcinoma tissue array, 33 cases 63 cores, replaced by PR809 |
US Biomax |
|
160€ |
|
Pub |
BC19019 Prostate cancer and hyperplasia tissue array, 33 cases 63 cores, replacing BC19011 US Biomax 231 |
BC19019 |
Prostate cancer and hyperplasia tissue array, 33 cases 63 cores, replacing BC19011 |
US Biomax |
|
231€ |
|
Pub |
BC24021 Leiomyosarcoma and Rhabdomyosarcoma tissue array with normal muscles controls, 39 cases 75 cores US Biomax 231 |
BC24021 |
Leiomyosarcoma and Rhabdomyosarcoma tissue array with normal muscles controls, 39 cases 75 cores |
US Biomax |
|
231€ |
|
Pub |
BC27011 Multiple organs, diseased tissue array of oral cavity, 47 cases 48 cores US Biomax 189 |
BC27011 |
Multiple organs, diseased tissue array of oral cavity, 47 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
BC30011 Heart tissue array, 13 cases 34 cores, replaced by BC30013 US Biomax 231 |
BC30011 |
Heart tissue array, 13 cases 34 cores, replaced by BC30013 |
US Biomax |
|
231€ |
|
Pub |
BC30013 Heart disease and normal tissue array, replacing BC30011, 18 cases 36 cores US Biomax 231 |
BC30013 |
Heart disease and normal tissue array, replacing BC30011, 18 cases 36 cores |
US Biomax |
|
231€ |
|
Pub |
BC34111 Multiple head and neck squamous cell carcinoma tissue array with normal tissue, 36 cases 72 cores, replaced by HN811 US Biomax 160 |
BC34111 |
Multiple head and neck squamous cell carcinoma tissue array with normal tissue, 36 cases 72 cores, replaced by HN811 |
US Biomax |
|
160€ |
|
Pub |
BC35111 Retinoblastoma and normal adjacent tissue array, 17 cases 34 cores US Biomax 189 |
BC35111 |
Retinoblastoma and normal adjacent tissue array, 17 cases 34 cores |
US Biomax |
|
189€ |
|
Pub |
BCN801 Multiple organ cancer with adjacent tissue combined panel tissue array, 48 cases 80 cores US Biomax 231 |
BCN801 |
Multiple organ cancer with adjacent tissue combined panel tissue array, 48 cases 80 cores |
US Biomax |
|
231€ |
|
Pub |
BCN961 Multiple organ cancer tissue array with adjacent cancer tissue control tissue array, 57 cases 96 cores, replaced by BCN963 US Biomax 231 |
BCN961 |
Multiple organ cancer tissue array with adjacent cancer tissue control tissue array, 57 cases 96 cores, replaced by BCN963 |
US Biomax |
|
231€ |
|
Pub |
BCN963 Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 78 cases 96 cores, replacing BCN961 US Biomax 266 |
BCN963 |
Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 78 cases 96 cores, replacing BCN961 |
US Biomax |
|
266€ |
|
Pub |
BE01014 Multiple organ, normal fetus tissue array, 26 cases 78 cores US Biomax 189 |
BE01014 |
Multiple organ, normal fetus tissue array, 26 cases 78 cores |
US Biomax |
|
189€ |
|
Pub |
BE01015 Multiple organ, normal fetus tissue array, 50 cases 50 cores US Biomax 189 |
BE01015 |
Multiple organ, normal fetus tissue array, 50 cases 50 cores |
US Biomax |
|
189€ |
|
Pub |
BL1001 Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 |
BL1001 |
Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
BLC661 Bladder cancer tissue array, 33 cases 66 cores US Biomax 225 |
BLC661 |
Bladder cancer tissue array, 33 cases 66 cores |
US Biomax |
|
225€ |
|
Pub |
BN00011 Multiple organ normal tissue array, 48 cases 48 cores US Biomax 160 |
BN00011 |
Multiple organ normal tissue array, 48 cases 48 cores |
US Biomax |
|
160€ |
|
Pub |
BN00015 Multiple organ normal tissue array, 47 cases 48 cores US Biomax 160 |
BN00015 |
Multiple organ normal tissue array, 47 cases 48 cores |
US Biomax |
|
160€ |
|
Pub |
BN00112 Multiple organ normal tissue array, 40cases 40 cores, replaced by BN00119 US Biomax 160 |
BN00112 |
Multiple organ normal tissue array, 40cases 40 cores, replaced by BN00119 |
US Biomax |
|
160€ |
|
Pub |
BN00119 Multiple organ normal tissue array, 40 cases 40 cores, replacing BN00112 US Biomax 266 |
BN00119 |
Multiple organ normal tissue array, 40 cases 40 cores, replacing BN00112 |
US Biomax |
|
266€ |
|
Pub |
BN1002 Multiple organ (20) normal tissue array, 100 cases 100 cores, replacing BN1001 US Biomax 266 |
BN1002 |
Multiple organ (20) normal tissue array, 100 cases 100 cores, replacing BN1001 |
US Biomax |
|
266€ |
|
Pub |
BN113 Multiple organ normal tissue array, replaced by BN126, 45 cases 45 cores US Biomax 189 |
BN113 |
Multiple organ normal tissue array, replaced by BN126, 45 cases 45 cores |
US Biomax |
|
189€ |
|
Pub |
BN114 Multiple normal human organ tissue array, 48 cases 48 cores US Biomax 189 |
BN114 |
Multiple normal human organ tissue array, 48 cases 48 cores |
US Biomax |
|
189€ |
|
Pub |
BN115 Multiple organ normal tissue array, 46 cases 46 cores US Biomax 189 |
BN115 |
Multiple organ normal tissue array, 46 cases 46 cores |
US Biomax |
|
189€ |
|
Pub |
BN116 Multiple organ normal tissue array, 48 cases 48 cores, replaced by BN129 US Biomax 189 |
BN116 |
Multiple organ normal tissue array, 48 cases 48 cores, replaced by BN129 |
US Biomax |
|
189€ |
|
Pub |
BN117 Multiple organ normal tissue array, 45 cases 45 cores US Biomax 189 |
BN117 |
Multiple organ normal tissue array, 45 cases 45 cores |
US Biomax |
|
189€ |
|
Pub |
BN126 Multiple organ normal tissue array, replacing BN113, 45 cases 45 cores US Biomax 231 |
BN126 |
Multiple organ normal tissue array, replacing BN113, 45 cases 45 cores |
US Biomax |
|
231€ |
|
Pub |
BN129 Multiple organ adjacent normal tissue array, 48 cases 48 cores, replacing BN116 US Biomax 160 |
BN129 |
Multiple organ adjacent normal tissue array, 48 cases 48 cores, replacing BN116 |
US Biomax |
|
160€ |
|
Pub |
BN484 Multiple organ normal tissue array, 24 cases 48 cores US Biomax 231 |
BN484 |
Multiple organ normal tissue array, 24 cases 48 cores |
US Biomax |
|
231€ |
|
Pub |
BN501 Normal human top 10 organ tissue array, 50 cases 50 cores, replacing BN00012 and BN00013 US Biomax 160 |
BN501 |
Normal human top 10 organ tissue array, 50 cases 50 cores, replacing BN00012 and BN00013 |
US Biomax |
|
160€ |
|
Pub |
BN961 Normal human tissue panel (24 organs) with two serial tissue array sections in parallel, 24 cases 102 cores, replacing BN861 US Biomax 266 |
BN961 |
Normal human tissue panel (24 organs) with two serial tissue array sections in parallel, 24 cases 102 cores, replacing BN861 |
US Biomax |
|
266€ |
|
Pub |
BR01015 Multiple organ, normal tissue array, 8 normal tissues, 160 cases 160 cores, replacing BR01011 US Biomax 278 |
BR01015 |
Multiple organ, normal tissue array, 8 normal tissues, 160 cases 160 cores, replacing BR01011 |
US Biomax |
|
278€ |
|
Pub |
BR041 Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases 4 cores, replaced by BR042a US Biomax 88 |
BR041 |
Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases 4 cores, replaced by BR042a |
US Biomax |
|
88€ |
|
Pub |
BR082 Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases 8 cores US Biomax 112 |
BR082 |
Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases 8 cores |
US Biomax |
|
112€ |
|
Pub |
BR1007 Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores US Biomax 266 |
BR1007 |
Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
BR1009 Breast cancer tissue array for antibody screening , including TNM and pathology grade, 50 cases 100 cores US Biomax 266 |
BR1009 |
Breast cancer tissue array for antibody screening , including TNM and pathology grade, 50 cases 100 cores |
US Biomax |
|
266€ |
|
Pub |
BR1502 Breast cancer mid density tissue array, wiht AR ER PR Her 2 P53 EGFR Ki67 IHC results, 75 cases 150 cores, replaced by BR1503 US Biomax 278 |
BR1502 |
Breast cancer mid density tissue array, wiht AR ER PR Her 2 P53 EGFR Ki67 IHC results, 75 cases 150 cores, replaced by BR1503 |
US Biomax |
|
278€ |
|
Pub |
BR1503 Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her 2, ER, PR, P53 and Ki 67, 75 cases 150 cores, replacing BR1502 US Biomax 278 |
BR1503 |
Breast cancer tissue array, including TNM and pathology grade, with IHC results of Her 2, ER, PR, P53 and Ki 67, 75 cases 150 cores, replacing BR1502 |
US Biomax |
|
278€ |
|
Pub |
BR601 Breast fibroma and sclerosing adenosis tissue microarray, 30 cases 60 cores US Biomax 231 |
BR601 |
Breast fibroma and sclerosing adenosis tissue microarray, 30 cases 60 cores |
US Biomax |
|
231€ |
|
Pub |
BR6161 High density breast cancer tissue array, with stage, grade and normal breast tissue, 322 cases 616 cores US Biomax 753 |
BR6161 |
High density breast cancer tissue array, with stage, grade and normal breast tissue, 322 cases 616 cores |
US Biomax |
|
753€ |
|
Pub |
BR701 Breast cancer tissue array, 70 cases 70 cores, with TNM data plus ER, PR and Her 2 (C erbB 2, neu< em>) IHC results, replaced by BR962 US Biomax 231 |
BR701 |
Breast cancer tissue array, 70 cases 70 cores, with TNM data plus ER, PR and Her 2 (C erbB 2, neu< em>) IHC results, replaced by BR962 |
US Biomax |
|
231€ |
|
Pub |
BR961 Breast cancer array with normal and other non malignant breast tissues, with AR, ER, PR, Her 2 (neu) IHC results, 48 cases 96 cores, replaced by BR962 US Biomax 0 |
BR961 |
Breast cancer array with normal and other non malignant breast tissues, with AR, ER, PR, Her 2 (neu) IHC results, 48 cases 96 cores, replaced by BR962 |
US Biomax |
|
0€ |
|
Pub |
BR962 Breast cancer array with normal and other non malignant breast tissues, with AR, ER, PR, Her 2 (neu) IHC results, 48 cases 96 cores, replacing BR961, BR701 US Biomax 231 |
BR962 |
Breast cancer array with normal and other non malignant breast tissues, with AR, ER, PR, Her 2 (neu) IHC results, 48 cases 96 cores, replacing BR961, BR701 |
US Biomax |
|
231€ |
|
Pub |
BR963 Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her 2, Ki67, CK14 and p53), 48 cases 96 cores, replacing BR962 US Biomax 314 |
BR963 |
Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her 2, Ki67, CK14 and p53), 48 cases 96 cores, replacing BR962 |
US Biomax |
|
314€ |
|
Pub |
BRC961 Breast cancer array with normal and other non malignant breast tissues, non overlapping with BRC962, with AR ER PR Her 2(neu) IHC results, 48 cases 96 cores US Biomax 225 |
BRC961 |
Breast cancer array with normal and other non malignant breast tissues, non overlapping with BRC962, with AR ER PR Her 2(neu) IHC results, 48 cases 96 cores |
US Biomax |
|
225€ |
|
Pub |
bs-0004R-A350 Rabbit Anti-ACTH (7-23) Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 |
bs-0004R-A350 |
Rabbit Anti-ACTH (7-23) Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG |
Sepax |
100ug Lyophilized |
323€ |
|
Pub |
bs-0009R-A350 Rabbit Anti-alpha-Synuclein(NT) Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 |
bs-0009R-A350 |
Rabbit Anti-alpha-Synuclein(NT) Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG |
Sepax |
100ug Lyophilized |
323€ |
|
Pub |
bs-0012M-A350 Mouse Anti-α-Synuclein Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 |
bs-0012M-A350 |
Mouse Anti-α-Synuclein Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG |
Sepax |
100ug Lyophilized |
323€ |
|
Pub |
bs-0014R-A350 Rabbit Anti-IGF I Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 |
bs-0014R-A350 |
Rabbit Anti-IGF I Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG |
Sepax |
100ug Lyophilized |
323€ |
|
Pub |
bs-0016R-A350 Rabbit Anti-Tyrosine Hydroxylase(Neuronal Marker) Tyk2 TYH Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 |
bs-0016R-A350 |
Rabbit Anti-Tyrosine Hydroxylase(Neuronal Marker) Tyk2 TYH Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG |
Sepax |
100ug Lyophilized |
323€ |
|
Pub |
bs-0017M-A350 Mouse Anti-Galanin Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 |
bs-0017M-A350 |
Mouse Anti-Galanin Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG |
Sepax |
100ug Lyophilized |
323€ |
|
Pub |
bs-0019R-A350 Rabbit Anti-OPN BSP Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 |
bs-0019R-A350 |
Rabbit Anti-OPN BSP Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG |
Sepax |
100ug Lyophilized |
323€ |
|
Pub |
bs-0021M-A350 Mouse Anti-ERAB HSD17B10 Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 |
bs-0021M-A350 |
Mouse Anti-ERAB HSD17B10 Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG |
Sepax |
100ug Lyophilized |
323€ |
|
Pub |
bs-0022R-A350 Rabbit Anti-ERK2 MAPK1 Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 |
bs-0022R-A350 |
Rabbit Anti-ERK2 MAPK1 Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG |
Sepax |
100ug Lyophilized |
323€ |
|
Pub |
bs-0023M-A350 Mouse Anti-GSK-3β (NT) Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 |
bs-0023M-A350 |
Mouse Anti-GSK-3β (NT) Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG |
Sepax |
100ug Lyophilized |
323€ |
|
Pub |
bs-0023M-A488 Mouse Anti-GSK-3β (NT) Polyclonal Antibody, Alexa Fluor 488 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 |
bs-0023M-A488 |
Mouse Anti-GSK-3β (NT) Polyclonal Antibody, Alexa Fluor 488 conjugated,Isotype: IgG |
Sepax |
100ug Lyophilized |
323€ |
|
Pub |